Steam Turbine

A turbine composed of moving nozzles alternating with fixed nozzles is called a reaction turbine or Parsons turbine.

An ideal steam turbine is considered to be an isentropic process, or constant entropy process, in which the entropy of the steam entering the turbine is equal to the entropy of the steam leaving the turbine.

When warming up a steam turbine for use, the main steam stop valves have a bypass line to allow superheated steam to slowly bypass the valve and proceed to heat up the lines in the system along with the steam turbine.

After first rotating the turbine by the turning gear, allowing time for the rotor to assume a straight plane, then the turning gear is disengaged and steam is admitted to the turbine, first to the astern blades then to the ahead blades slowly rotating the turbine at 10-15 RPM to slowly warm the turbine.

Steam’s starting pressure and temperature is the same for both the actual and the ideal turbines, but at turbine exit, steam’s energy content for the actual turbine is greater than that for the ideal turbine because of irreversibility in the actual turbine.

The first turbine was called the high pressure turbine, the last turbine was the low pressure turbine, and any turbine in between was an intermediate pressure turbine.

A steam turbine locomotive engine is a steam locomotive driven by a steam turbine.

Description And Characteristics

The most important turbine elements are the turbine blades.

In steam turbines, the steam expands through the fixed blade, where the pressure potential energy is converted to kinetic energy.

The rotor blades are usually designed like an impulse blade at the rot and like a reaction blade at the tip.

For gas turbines, the turbine blades are often the limiting component.

High content of water droplets can cause the rapid impingement and erosion of the blades which occurs when condensed water is blasted onto the blades.

The root is a constructional feature of turbine blades, which fixes the blade into the turbine rotor.

The shroud reduces the vibration of the blade which can be induced by the flowing of high pressure steam through the blades.

Steam Turbines

To minimize on-site assembly and rotor balancing, all our steam turbines are preassembled and fully tested with steam at our factory before delivery to the customer.

Mechanical running tests and string tests are available on request.

To reduce maintenance needs, we offer an advanced seals option.

We also provide a wide range of value-added services, including conversions, modifications, upgrades, and repairs to improve maintainability and operating costs over the entire lifecycle.

MAN Energy Solutions Steam Turbines

Special-purpose steam turbines to drive your process.

Our steam turbines are characterized by a variety of modular design features.

This keeps delivery time and cost at a minimum level.

MAN Energy Solutions has over 100 years of experience in developing steam turbines.

Range of MAN Energy Solutions steam turbine power generation.

Pdf, 1112 KB. Businesses all over the world rely on our modular and scalable steam turbine solutions.

MAN Energy Solutions experts are always at hand to support your business, too.

How Steam Energy Works

A steam turbine generator works by heating water to extremely high temperatures until it is converted into steam, then the steam energy is used to rotate the blades of a turbine to create mechanical or rotational energy.

This rotational energy caused by the high pressured steam turbine is used to generate electricity from an attached generator.

In the diagram below we see a simplified example of how a steam energy turbine works.

The boiler, which contains water, uses the heat energy to convert the water into high pressure steam.

If the system uses solar energy for the heat conversion, then an exhaust pipe is not needed because the solar energy system will not release any pollutants.

The steam from the water in the boiler is pumped into the steam turbine.

The remaining water that is cooled back into a liquid state is pumped back into the boiler and repeats the process again, creating more energy from steam.

Steam Turbines: Basics, Types, Selection, Components, Construction, Codes, Manufacturers

A Steam Turbine is an engine that converts heat energy from pressurized steam into mechanical energy where the steam is expanded in the turbine in multiple stages to generate the required work.

In the reaction steam turbine, a jet of steam flows from a nozzle on the rotor by fixed blades designed to expand the steam.

Type of Steam TurbineGeneral FeaturesSelection CriteriaUse forCondensing Steam TurbineThe turbines which work fully inflated to low pressure by obtained high vacuum in order to condense turbine exhaust steam in the condenser.

Large scale power generationBack pressure Steam TurbineThe turbines that exhaust pressure are above atmospheric pressure and utilize steam as utility steam.

Private power generation, machine drive, cogenerationExtraction condensing Steam TurbineThe turbines which extract steam from middle stage of condensing turbine after adjusting pressure by control valve and utilize steam and exhaust steam as utility steam for works and others.

Private power generation, machine drive, cogenerationExtraction back pressure Steam turbineThe turbines which extract steam from middle stage of back pressure turbine after adjusting pressure by control valve and utilize steam and exhaust steam as utility steam for works and others.

Steam Turbine Codes and Standards API 611 4th Edition – General purpose steam turbines for refinery service: General purpose turbines are horizontal or vertical turbines used to drive equipment that is usually spared, is relative small in size, or is in non-critical service.

Steam Calculators: Steam Turbine Calculator

Calculates the energy generated or steam outlet conditions for a steam turbine.

Calculation Details Step 1: Determine Inlet Properties Using the Steam Property Calculator, properties are determined using Inlet Pressure and the selected second parameter.

Introduction To Web Accessibility

Accessibility is essential for developers and organizations that want to create high-quality websites and web tools, and not exclude people from using their products and services.

Web accessibility means that websites, tools, and technologies are designed and developed so that people with disabilities can use them.

For a 7-minute video with examples of how accessibility is essential for people with disabilities and useful for everyone in a variety of situations, see: Web Accessibility Perspectives Video.

Web accessibility depends on several components working together, including web technologies, web browsers and other “User agents”, authoring tools, and websites.

The W3C Web Accessibility Initiative develops technical specifications, guidelines, techniques, and supporting resources that describe accessibility solutions.

More Info on Making Your Website Accessible For an introduction to accessibility requirements and international standards, see Accessibility Principles.

To understand some common accessibility barriers from the perspective of testing, see Easy Checks – A First Review of Web Accessibility.

Web Accessibility Professionals: ADA Web Design Solutions & Services

Web accessibility evaluation tools are software applications or online web services that help you determine if your web content meets accessibility guidelines.

These gatherings allow for networking opportunities to connect with Web Accessibility professionals.

Through these upcoming 2020 conferences, you can prepare to address common issues surrounding web accessibility and create solutions that provide a better user experience for people with disabilities on the web.

Charlie is passionate about helping business leaders understand the benefit of web accessibility.

Giovani Camara is a front end web developer with a focus on web accessibility and user experience.

The “De-facto” standard is the WCAG v2.1 Level AA published in June, 2018 by the W3C, but it is important to remember that this standard has not been adopted as officially complying with the ADA. To help comply with this standard it is recommended to test your website through a series of web accessibility audits and then focusing on fixing any possible errors.

The Web Content Accessibility Guidelines, often abbreviated as WCAG, are a series of guidelines for improving web accessibility.

Web Accessibility: What Is It And Why Is It Important?

When defining web accessibility, the World Wide Web Consortium has written that “Web accessibility means that websites, tools, and technologies are designed and developed so that people with disabilities can use them”.

As Web accessibility experts Level Level argues that “Everyone benefits from improved web accessibility.”

Accessibility encompasses a broad range of issues that affect access to the web – from disabilities, including temporary disabilities, to situational limitations, and issues with technology or the internet.

If the ethical standpoint isn’t enough to win you over on the importance of web accessibility, then the business case for accessibility may help.

W3C has produced Web Content Accessibility Guidelines which are internationally recognized guidelines for improving web accessibility.

Gravity Forms is fully committed to accessibility and making the web accessible to everyone.

With Gravity Forms 2.5, you will find accessibility changes across the board, turning our form builder into an accessibility tool that can be used to create forms that achieve WCAG 2.1 AA compliance.

What Is Accessibility?

This article starts the module off with a good look at what accessibility is – this overview includes what groups of people we need to consider and why, what tools different people use to interact with the web, and how we can make accessibility part of our web development workflow.

Websites must conform with the W3C’s Web Content Accessibility Guidelines, including cognitive accessibility guidelines.

The W3C’s Cognitive and Learning Disabilities Accessibility Task Force produces web accessibility guidelines for people with cognitive impairments.

A common accessibility myth is that accessibility is an expensive “Added extra” to implement on a project.

You are trying to “Retrofit” accessibility onto an existing website that has significant accessibility issues.

So while the WCAG is a set of guidelines, your country will probably have laws governing web accessibility, or at least the accessibility of services available to the public It is a good idea to find out what your laws are.

Where the native semantic information provided by the HTML elements in your web apps falls down, you can supplement it with features from the WAI-ARIA specification, which add semantic information to the accessibility tree to improve accessibility.

Why Web Accessibility Is Important

Faculty, staff, and students are often unsure of what we mean when we speak of web accessibility.

Web accessibility is an issue that is relevant to all people, not just for those with a disability.

To be most effective, web accessibility must be addressed proactively, and involves educating oneself about accessibility, creating accessible content, and making that content readily available to all online users.

The following three videos from W3C Web Accessibility Initiative puts web accessibility into perspective, addressing why it is both essential and useful.

Web accessibility works to inclusively enable access to a website by all users, regardless of the user’s level of ability, condition, or circumstances.

Violating these laws can result in a loss of funding, as some universities have faced legal action for web accessibility non-compliance.

The University of Washington has developed thorough summaries of several higher education resolution agreements and lawsuits involving web accessibility.

Free Online Web Accessibility Checker

The part that affects the way business communicates with customers online is called “Title III”, therefore often when web accessibility is discussed, it’s being referred to as ADA Title III. ADA Title III is not a set of standards, it’s US-based legislation, enforcing private websites to comply with the WCAG 2.1 Accessibility Guidelines.

You can use a web accessibility checker to ensure your website is compliant.

Among other topics, the AODA clearly defines the need for website accessibility compliance, like most web accessibility legislation, based on W3C’s WCAG 2.0 Guidelines.

Established on 11 July 2019 by the ESDC, and enforced by a dedicated accessibility commissioner and a governmental council called the ASDO, it’s clear that Canada takes online accessibility seriously.

AC’s mission is to arm businesses with the most accurate, up to date and reliable information regarding web accessibility in order to avoid lawsuits, and in turn, help scale up web accessibility and create an easy, seamless web experience for the wider disabled community.

The Accessibility Checker auditing tool has no legal authority, but it does provide a detailed analysis of your website’s accessibility state that can be used to help your team decide on a course of action.

The accessibility checker auditing tool scans your website and checks for accessibility errors and issues worldwide and local standards and legislations.

Web Accessibility

According to a 2018 WebAIM global survey of web accessibility practitioners, close to 93% of survey respondents received no formal schooling on web accessibility.

The Standard on Web Accessibility follows the Web Content Accessibility Guidelines 2.0 AA, and contains a list of exclusions that is updated annually.

In Ireland, the Disability Act 2005 requires that where a public body communicates in electronic form with one or more persons, the contents of the communication must be, as far as practicable, “Accessible to persons with a visual impairment to whom adaptive technology is available” by “Reviewing existing practices for electronic communications in terms of accessibility against relevant guidelines and standards”, giving the example of “Double A conformance with the Web Accessibility Initiative’s Web Content Accessibility Guidelines”.

In Malta Web Content Accessibility assessments were carried out by the Foundation for Information Technology Accessibility since 2003.

In Norway, web accessibility is a legal obligation under the Act 20 June 2008 No 42 relating to a prohibition against discrimination on the basis of disability, also known as the Anti-discrimination Accessibility Act.

In 2019 new accessibility regulations came into force setting a legal duty for public sector bodies to publish accessibility statements and make their websites accessible by 23 September 2020 Accessibility statements include information about how the website was tested and the organisation’s plan to fix any accessibility problems.

Once an accessibility audit has been conducted, and accessibility errors have been identified, the errors will need to be remediated in order to ensure the site is compliant with accessibility errors.

Pilot Experiment

A pilot study, pilot project, pilot test, or pilot experiment is a small-scale preliminary study conducted to evaluate feasibility, duration, cost, adverse events, and improve upon the study design prior to performance of a full-scale research project.

A pilot study is used to formulate the design of the full-scale experiment which then can be adjusted.

The pilot study is potentially a critical insight to clinical trial design, recruitment and sample size of participants, treatment testing, and statistical analysis to improve the power of testing the hypothesis of the study.

Analysis from the pilot experiment can be added to the full-scale experiment to improve the chances of a clear outcome.

Extrapolation from a pilot study to large scale strategy may not be assumed as possible, partly due to the exceptional resources and favorable conditions that accompany a pilot study.

In clinical research, studies conducted in preparation for a future randomized controlled trial are known as “Pilot” and “Feasibility” studies, where pilot studies are a subset of feasibility studies.

A pilot study asks the same questions, but also has a specific design feature: in a pilot study, a future study is conducted on a smaller scale, which, if having produced positive results, may lead to a Phase I clinical trial.

Pilot Experiments

My model said, irrespective of the size or rate of growth of the fires, they should be fought in order of their age, younger fires before older ones.

Fire A should be set H hous after fire B, so fire A is the yougest fire.

My hypothesis was that in the 16 conditions in which fire A, the youngest fire, was fought first, the time to contain both fires would be less than in the other 16 conditions.

It was clear before I ran the experiment that the time required to fight the fires would vary considerably across the conditions; for example, a pair of large, fast-growing fires would take longer to contain than one large and one small, slow-growing fire.

In particular, I had no idea how to set the parameter H, the age difference between the fires, although my model said that the advantage of the youngest-first strategy ought to be proportional to H. Because the models we test in experiments are incomplete or imprecise, we often do not know how to set the values of independent variables to best see effects on dependent variables.

How slow should “slow growth” be? How large is a “large” fire?

Or pieces of code that implement the experimental procedure can be buggy; for example, because fires are reported by watchtowers, which sometimes fail, I found in a pilot experiment that roughly half of my “youngest fire first” trials actually fought the oldest fire first!

Definition Of Pilot Experiment By The Free Dictionary

Pilot experiment – a preliminary experiment whose outcome can lead to a more extensive experimentexperimentation, experiment – the testing of an idea; “It was an experiment in living”; “Not all experimentation is done in laboratories”.

Based on WordNet 3.0, Farlex clipart collection.

Definition Of Pilot By Medical Dictionary

The two main types are prospective studies and retrospective studies.

It contrasts with a cross-sectional s. pilot study a smaller version of a proposed research study, conducted to refine the methodology of the later one.

Prospective study an epidemiologic study in which the groups of individuals are selected on the bases of factors that are to be examined for possible effects on some outcome.

Retrospective study an epidemiologic study in which participating individuals are classified as either having some outcome or lacking it; the outcome may be a specific disease, and the persons’ histories are examined for specific factors that might be associated with that outcome.

As compared to prospective studies, retrospective studies suffer from drawbacks: certain important statistics cannot be measured, and large biases may be introduced both in the selection of controls and in the recall of past exposure to risk factors.

The advantage of the retrospective study is its small scale, usually short time for completion, and its applicability to rare diseases, which would require study of very large cohorts in prospective studies.

Pilot study Pilot project Medtalk A preliminary study designed to evaluate the effect of a particular change in policy.

Warner Bros. Pictures

Pictures is an American film production and distribution division of Warner Bros.

The studio is the flagship producer of live-action feature films within the Warner Bros.

Pictures is currently one of five live-action film studios within the Warner Bros.

Founded in 1923 by brothers Harry Warner, Albert Warner, Sam Warner, and Jack L. Warner, in addition to producing its own films, it handles filmmaking operations, theatrical distribution, marketing and promotion for films produced and released by other Warner Bros.

Pictures revolutionized the film industry when the American-Jewish Warner brothers released their first pictures “Talkie” The Jazz Singer starring Al Jolson.

Pictures on March 3, 2003, to diversify film subjects and expand audiences for their film releases.

Pictures to alter its compensation rates for the affected films by January 2021 to provide larger payouts to casts and crews of these films.

Warner Bros. Studio Operations

Studio Operations oversees the physical operation of Warner Bros.

Studios, one of the foremost motion picture and television production and post-production facilities in the industry.

We are a worldwide operation, managing three studios – Warner Bros.

In Burbank, we offer a wide range of production rentals & services, taking you from prep through post.

From Set Lighting and Grip to Property and Costume we are here to support productions of all types.

Our Post Production Creative Services provides exceptional picture and sound post for the most inspiring filmmakers and storytellers worldwide.

Our complete post production house offers the finest talent, industry-leading facilities, and cutting-edge technologies in Burbank, New York and London.

Warner Bros Discovery Merger Has Officially Concluded

Has officially come to a close and the combined company will be known as Warner Bros.

It has been announced that the deal is now officially closed and Warner Bros.

WarnerMedia CEO Jason Kilar is exiting the newly combined company, and Discovery CEO David Zaslav will be running the combined operations going forward.

Toby Emmerich, Casey Bloys and Channing Dungey, heads of Warner Bros Pictures, HBO and Warner Bros TV, respectively, have gotten votes of confidence to retain their positions.

This new deal makes for a gigantic media entity between the two former companies.

Discovery includes Discovery Plus, Discovery Channel, HGTV, Food Network, TLC, Investigation Discovery, Travel Channel, Turbo/Velocity, Animal Planet, Science Channel, and OWN. The new company will begin trading on the stock exchange on Monday under the ticker symbol WBD. With HBO Max and Discovery Plus both existing as streaming services, a consolidation of the two services is inevitable, but won’t happen immediately.

Town hall meetings are scheduled for next week for details of new initiatives to be shared with all of the company’s divisions.

Warner Bros Discovery Merger Closes

UPDATED REPORT: The $43bn merger between WarnerMedia and Discovery has closed, resulting in entertainment giant Warner Bros Discovery which begins trading on the Nasdaq on Monday.

“With our collective assets and diversified business model, Warner Bros. Discovery offers the most differentiated and complete portfolio of content across film, television and streaming. We are confident that we can bring more choice to consumers around the globe while fostering creativity and creating value for shareholders. I can’t wait for both teams to come together to make Warner Bros. Discovery the best place for impactful storytelling.”

In addition to their new shares of Warner Bros Discovery common stock, AT&T shareholders continue to hold the same number of shares of AT&T common stock they held immediately prior to close.

ORIGINAL REPORT: David Zaslav has unveiled several members of his key executive suite, fuelling speculation that the $43bn Warner Bros Discovery merger will conclude very soon, possibly by tomorrow.

According to reports Warner Bros Pictures chairman Toby Emmerich is staying and will report directly to Zaslav, as will HBO/HBO Max chief content officer Casey Bloys, and Warner Bros TV Group head Channing Dungey.

Key Discovery executives include Bruce Campbell, the chief development, distribution and legal officer who becomes Discovery Warner Bros chief revenue and strategy officer.

Discovery president and CEO of streaming and international JB Perrette becomes CEO and president of Warner Bros Discovery Global Streaming and Interactive Entertainment, a large remit that encompasses streaming including HBO/HBO Max and Discover+, direct-to-consumer, and gaming.

Warner Bros Discovery Merger Closes, Altering Media Landscape

Discovery and WarnerMedia have closed their long-awaited mega-merger, creating a top-scale media player and streaming contender and ending an ill-fated foray into entertainment by AT&T. The combination will unite such disparate assets as HBO, CNN and the nearly 100-year-old Warner Bros film studio with unscripted programming juggernauts like Food Network, HGTV and 90 Day Fiancé.

Warner Bros Discovery stock is expected to begin full trading Monday under the ticker symbol “WBD.” It has already begun changing hands on a “When issued” basis.

In the announcement of the deal’s close Friday, Zaslav called it “An exciting milestone not just for Warner Bros. Discovery but for our shareholders, our distributors, our advertisers, our creative partners and, most importantly, consumers globally,” Zaslav said.

“With our collective assets and diversified business model, Warner Bros. Discovery offers the most differentiated and complete portfolio of content across film, television and streaming.”

With legacy businesses still throwing off billions in free cash flow, Warner Bros Discovery is not likely to make a headlong move into streaming, however.

Scripted film and TV projects are also relatively uncharted waters for Zaslav and the Discovery team, apart from OWN. Not only has Zaslav steered Discovery toward unscripted but he has derided the crush of companies entering the scripted space.

As Discovery absorbed Scripps and its portfolio of lifestyle networks, he favored a metaphor of a kids’ soccer game, with a bunch of kids chasing the scripted ball and Discovery in an open part of the field looking to score unscripted.

Warner Bros. Studio Logo – Devastudios

Creating a motion logo for a studio is a balancing act between honoring the rich traditions of the studio, while finding a new way to encapsulate that legacy for today’s audiences.

Updated the design of the WB logo last year with the talented team at Pentagram, and commissioned Devastudios to create a new motion logo to compliment that brand identity.

Motion logo, the lot transforms into a reflection in the side of the famous shield emblem, rippling as the bevels swoop by the camera.

The gold transforms into platinum as the Warner Bros.

Shield soars triumphantly over a vast CG cloudscape.

The new motion logo respects the heritage of Warner Bros.

While facing the future with a confident and contemporary brand statement.

Moonshot streaming exclusively on #HBOMax March 31.

Sundance Festival Favorite NAVALNY comes to theaters April 11 & 12 featuring a special conversation with filmmakers.

Treat yourself to “a rom-com that feels new again.” #Moonshot is NOW STREAMING exclusively on.

We know chemistry when we see it 👀. #Moonshot is NOW STREAMING exclusively on.

Pull up a seat, #Moonshot is NOW STREAMING exclusively on.

Watch + in the rom-com must see #Moonshot NOW STREAMING exclusively on.

Moonshot stars and have a delightful and infectious energy when they get together! These two couldn’t stop cracking up as they dished on all things space and romance.

Rubius Therapeutics Reports Updated Clinical Data At AACR From The Ongoing Monotherapy Phase 1 Arm Of The Phase 1/2 Clinical Trial Of RTX-240 In Advanced Solid Tumors Demonstrating Single-Agent Activity And Favorable Tolerability

CAMBRIDGE, Mass., April 08, 2022 – Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced updated clinical data from the ongoing monotherapy Phase 1 arm of the Phase 1/2 clinical trial of RTX-240 in patients with advanced solid tumors at the American Association for Cancer Research Annual Meeting.

“In this Phase 1 trial of heavily pretreated patients with advanced solid tumors, RTX-240 demonstrated single-agent activity with encouraging tolerability results, including in patients whose disease had progressed on prior PD-1/PD-L1-based treatment regimens. Based on these data, I believe RTX-240 has the potential to be an ideal candidate to be developed as a combination therapy with immune checkpoint inhibitors, especially in earlier lines of therapy.”

“Immune agonists and cytokines have been the focus of oncology research given their known importance for immune activation. However, current approaches have been unable to overcome toxicity challenges, resulting in a narrow therapeutic index, particularly in combination with checkpoint inhibitors. With today’s updated clinical data showing that RTX-240 generated clinical responses with favorable tolerability results in patients whose tumors had progressed on therapy with anti-PD-1/PD-L1 antibodies, we believe these data support the potential of immune agonists for the treatment of cancer,” sai Larry Turka, M.D., chief scientific officer and head of translational medicine at Rubius Therapeutics.

“Given the clinical results observed, we are expanding the ongoing Phase 1 arm of RTX-240 in combination with pembrolizumab to patients with NSCLC and RCC who have had fewer prior treatment regimens. This cohort is expected to inform our strategy of advancing RTX-240 in combination with pembrolizumab in a Phase 2 clinical trial.”

Final Phase 1 Clinical Results in Relapsed/Refractory AML. Rubius also announced final clinical results from the Phase 1 arm of monotherapy RTX-240 in relapsed/refractory AML. As of the cutoff date of March 4, 2022, seventeen patients were enrolled across 4 dose levels.

Report initial Phase 1 clinical results for RTX-321 for the treatment of HPV 16-positive cancers during the second half of 2022;.Report initial Phase 1 clinical results for RTX-240 in combination with pembrolizumab in advanced solid tumors and data from the additional NSCLC and RCC patients in the second half of 2022;.Select a clinical candidate for the first autoimmune program in type 1 diabetes during the second half of 2022; and.

The trial has three separate Phase 1 arms: a monotherapy dose escalation arm in adults with relapsed/refractory or locally advanced solid tumors, a monotherapy dose escalation arm in adults with relapsed/refractory acute myeloid leukemia, and a combination therapy dose escalation arm with pembrolizumab in adults with relapsed/refractory or locally advanced solid tumors.

AACR22: Rubius Touts New Data For Lead Program, But Shares Routed As Investors Flee – Endpoints News

AACR22: Rubius touts new data for lead program, but shares routed as investors flee – Endpoints News AACR22: Ru­bius touts new da­ta for lead pro­gram, but shares rout­ed as in­vestors flee.

Looking to build on its first cut of human data from last year, Rubius Therapeutics is touting new Phase I data from its lead cancer program in both solid tumors and acute myeloid leukemia.

Right on the heels of back-to-back breakthrough therapy designations for its lead RSV vaccine, Pfizer is wagering up to $525 million on a biotech buyout that injects new RSV assets into its pipeline.

Pfizer is snapping up ReViral after inspecting mid-stage data for sisunatovir, an oral drug that blocks the fusion of RSV with host cells.

“Monoclonal antibodies directed against amyloid that are approved by FDA for the treatment of AD based upon evidence of efficacy from a change in a surrogate endpoint considered as reasonably likely to predict clinical benefit may be covered in a randomized controlled trial conducted under an investigational new drug application,” CMS said in its final decision summary.

As Congress grapples with how to reform and lower prescription drug costs and may have to settle for a $35 monthly insulin cap, new research points to the concerning extent to which seniors skip out on their medicines because of high prices.

For those who are on expensive or “Specialty” drugs, these high up-front costs may result in seniors never starting a new drug, which was the case in four different treatment areas that the researchers, led by Vanderbilt’s Stacie Dusetzina and Harvard’s Haiden Huskamp, wrote about in Health Affairs.

28 Stocks Moving In Friday’S Mid-Day Session

Gainers Lyra Therapeutics, Inc. shares climbed 33.3% to $5.78 as the company reported a private placement for gross proceeds of $110.5 million.

Aterian, Inc. shares gained 12.2% to $4.3201 amid retail investor interest on social media.

MedAvail Holdings, Inc. jumped 71% to $2.4102 on continued strength after Ally Bridge Group on Wednesday reported in a Form 4 filing a purchase of roughly 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.

Sunshine Biopharma, Inc. shares fell 23.5% to $7.38 after surging 53% on Thursday.

Sunshine Biopharma, Inc. fell 21% to $7.62 after the company announced a common stock offering of approximately 7.207 million shares.

FTC Solar, Inc. fell 17.6% to $3.81 after Piper Sandler downgraded the stock from Overweight to Neutral and announced a $4 price target.

Rackspace Technology, Inc. fell 11.3% to $9.70 after Oppenheimer downgraded the stock from Outperform to Perform.

Rubius Therapeutics

The company’s proprietary RED PLATFORM® was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent, and off-the-shelf allogeneic cellular therapies for the potential treatment of diseases across multiple therapeutic areas.

RCT product candidates can be engineered to express combinations of costimulatory molecules and cytokines on their cell surface to directly engage both the adaptive immune system and the innate immune system.

RTX-240 is an allogeneic cellular therapy product candidate that simultaneously presents hundreds of thousands of copies of the costimulatory 4-1BB ligand and the trans-presented cytokine interleukin-15 in their native forms to activate and expand natural killer and T cells.

IL-15 is a cytokine that bridges innate and adaptive immunity by promoting NK and T cell proliferation and NK cell cytotoxicity.

RTX-321 is an investigational allogeneic artificial antigen-presenting cell, or aAPC, therapy that is engineered to induce a tumor-specific immune response by expanding antigen-specific T cells and promoting cytokine production and cytolytic activity, which could result in killing tumor cells.

Rubius can engineer cells to express specific autoimmune disease-associated antigens either within the cell or on its surface to take advantage of how the body normally maintains self-tolerance, thereby retraining the immune system to cease seeing self-antigens as foreign.

The company can express immune-modulating cytokines, enzymes, and inhibitory immune signals, which may have the potential to enhance the tolerogenic effects of Red Cell Therapeutics.

Rubius Therapeutics Reports Updated Clinical Data At AACR

CAMBRIDGE, Mass., April 08, 2022 – Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced updated clinical data from the ongoing monotherapy Phase 1 arm of the Phase 1/2 clinical trial of RTX-240 in patients with advanced solid tumors at the American Association for Cancer Research Annual Meeting.

“We believe the encouraging results of monotherapy RTX-240 reported provide clinical support of the RED PLATFORM® and the development of our entire oncology pipeline of Red Cell Therapeutics given the programmable nature of our platform,” said Pablo J. Cagnoni, M.D., president and chief executive officer.

Nine dose cohorts were completed in the monotherapy solid tumor arm of the trial at the time of the data cutoff on March 4, 2022, with 34 patients evaluable for safety and 27 patients evaluable for efficacy.

“Immune agonists and cytokines have been the focus of oncology research given their known importance for immune activation. However, current approaches have been unable to overcome toxicity challenges, resulting in a narrow therapeutic index, particularly in combination with checkpoint inhibitors. With today’s updated clinical data showing that RTX-240 generated clinical responses with favorable tolerability results in patients whose tumors had progressed on therapy with anti-PD-1/PD-L1 antibodies, we believe these data support the potential of immune agonists for the treatment of cancer,” said Larry Turka, M.D., chief scientific officer and head of translational medicine at Rubius Therapeutics.

“Given the clinical results observed, we are expanding the ongoing Phase 1 arm of RTX-240 in combination with pembrolizumab to patients with NSCLC and RCC who have had fewer prior treatment regimens. This cohort is expected to inform our strategy of advancing RTX-240 in combination with pembrolizumab in a Phase 2 clinical trial.”

Final Phase 1 Clinical Results in Relapsed/Refractory AML. Rubius also announced final clinical results from the Phase 1 arm of monotherapy RTX-240 in relapsed/refractory AML. As of the cutoff date of March 4, 2022, seventeen patients were enrolled across 4 dose levels.

Report initial Phase 1 clinical results for RTX-321 for the treatment of HPV 16-positive cancers during the second half of 2022;.Report initial Phase 1 clinical results for RTX-240 in combination with pembrolizumab in advanced solid tumors and data from the additional NSCLC and RCC patients in the second half of 2022;.Select a clinical candidate for the first autoimmune program in type 1 diabetes during the second half of 2022; and.

American Association For Cancer Research

Gary Steele’s cancer journey put him on a mission to educate himself and fellow African Americans about cancer disparities and the importance of participating in cancer clinical trials.

Research is driving progress to fulfill the great potential of liquid biopsy to benefit patients across the continuum of cancer care.

Million cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research.

Cancer diagnoses in the United States are associated with preventable risk factors.

Percent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2018.Learn MoreFor more statistics on cancer, please visit our Cancer Progress Report.

Cancer survivors in the United States are living with, through, and beyond their disease.

Your donation to the American Association for Cancer Research helps our more than 50,000 members worldwide drive progress against cancer.

SelectScience Is Covering The AACR 2022 Annual Meeting

News.SelectScience is covering the American Association for Cancer Research 2022 annual meeting.

Detailed here, are some of the key things to look out for.

Founded in 1907, the American Association for Cancer Research is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer.

This year’s meeting will bring together scientists, physicians, other healthcare professionals, survivors, patients, and advocates to discuss the most recent developments in cancer science and therapy, and will celebrate the latest work from institutions all around the world, ranging from population science and prevention; to cancer biology, translational, and clinical investigations.

SelectScience will be covering the news published by manufacturers, scientific breakthroughs, and more, and you can find this both on our website and on our social platforms.

Find the daily coverage of AACR by SelectScience by clicking here >>.

Genetron Health Presents 17 New Research Results At

BEIJING, April 08, 2022 – Genetron Holdings Limited, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the release of 17 research results at the American Association for Cancer Research Annual Meeting 2022.

These studies involved an in-depth analysis of the Chinese population, covering lung cancer, gastric cancer, colon cancer, bladder cancer, glioma, sarcoma, and other types of cancer.

More specifically, the studies focused on characteristics of each cancer, including mutation, fusion characteristics, hereditary tumor biomarkers, immunotherapy-associated biomarker screening, and molecular detection guidance of clinical typing, diagnosis and treatment, contributing to the scientific research and full-cycle clinical management of cancer.

“In the future, Genetron Health’s products and technologies will continue to contribute to the early diagnosis and clinical treatment of cancer patients,” Hu added.

HER2 antibody trastuzumab combined with chemotherapy is the frontline treatment option for patients with HER2-positive breast or gastric cancer.

Four studies explored pathogenic germline mutations in gliomas, sarcomas, and gastric cancers including HRR and MMR core genes and other key susceptibilities to hereditary genes, providing instructional guidance to early disease diagnosis, genetic counseling and treatment.

Genetron Holdings Limited is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment.

American Association For Cancer Research

The American Association for Cancer Research is the world’s oldest and largest professional association related to cancer research.

Based in Philadelphia, the AACR focuses on all aspects of cancer research, including basic, clinical, and translational research into the etiology, prevention, diagnosis, and treatment of cancer.

The mission of the AACR is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.

Larger International Conferences that recur on a regular basis, including collaborative programs such as the San Antonio Breast Cancer Symposium, Molecular Targets and Cancer Therapeutics Conference, the International Cancer Immunotherapy Conference, and the Biennial Meeting on Advances in Malignant Lymphoma;.

The AACR launched Cancer Discovery in 2011 as a selective journal for basic, translational, and clinical cancer research.

Research published in the journal includes identification of actionable genomic alterations in cancer, mechanisms of therapy resistance, clinical trials on targeted therapy, and cancer immunotherapy research including immune checkpoint blockade and Chimeric Antigen Receptor T-cell therapy.

Since establishing its grant program in 1993, the AACR has awarded more than $425 million in funding to more than 800 scientists for cancer research projects that aim to advance the understanding and treatment of cancer.

We’re thrilled to see so many people already engaged on social media at the AACR Annual Meeting 2022- more than 1,300 tweets so far.

AACR22Day 1 of the #AACR22 Educational Program-and of the first in-person AACR Annual Meeting in three years-is in the books.

Visit the Membership Center at AACR Central to check your membership status, apply for AACR membership, and learn more about member benefits and AACR programs and initiatives.

AACR Women in Cancer Research congratulates the recipients of the 2022 AACR WICR Scholar Awards.

AACR22 #ECR #AACRAMCThanks, Phaethon Philbrook, for sharing your grad school success tips, including: Find multiple related areas you are excited about so you can pivot if something doesn’t end up working out.

AACR22 #ECRCongratulations to Kimberly Stegmaier, MD, for being elected to the Board of Directors for her extensive work in #cancer research.

Ly/3LPyd0tWelcome to New Orleans! As Registration opens, we are excited that so many of you are able to join us in person at the AACR Annual Meeting.

28 Stocks Moving In Friday’S Mid-Day Session

Gainers Lyra Therapeutics, Inc. shares climbed 33.3% to $5.78 as the company reported a private placement for gross proceeds of $110.5 million.

Aterian, Inc. shares gained 12.2% to $4.3201 amid retail investor interest on social media.

MedAvail Holdings, Inc. jumped 71% to $2.4102 on continued strength after Ally Bridge Group on Wednesday reported in a Form 4 filing a purchase of roughly 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.

Sunshine Biopharma, Inc. shares fell 23.5% to $7.38 after surging 53% on Thursday.

Sunshine Biopharma, Inc. fell 21% to $7.62 after the company announced a common stock offering of approximately 7.207 million shares.

FTC Solar, Inc. fell 17.6% to $3.81 after Piper Sandler downgraded the stock from Overweight to Neutral and announced a $4 price target.

Rackspace Technology, Inc. fell 11.3% to $9.70 after Oppenheimer downgraded the stock from Outperform to Perform.

RUBY PIPELINE FILES TO REORGANIZE UNDER CHAPTER 11 OF THE BANKRUPTCY CODE

PRNewswire/ – Today, Ruby Pipeline, L.L.C., a natural gas pipeline joint venture between Kinder Morgan.

Filed to reorganize under chapter 11 of the Bankruptcy Code in response to an upcoming debt repayment obligation.

KMI will continue to operate the pipeline as chapter 11 permits daily operations to continue.

Ruby’s customers should notice no difference in its operations.

We will continue to keep Ruby’s customers and other stakeholders informed of developments relating to Ruby’s reorganization process.

Forward-looking statements in this news release include express or implied statements concerning the anticipated operations of Ruby and potential continued negotiations with Ruby’s bondholders.

Although Ruby believes that these forward-looking statements are based on reasonable assumptions, it can give no assurance as to when or if any such forward-looking statements will materialize or their ultimate impact on Ruby’s operations or financial condition.

Stock Quotes For RUBY Ent Holdg, NASDAQ: RUBY Fractional Shares, RUBY Stock Price, Charting, News

Gainers Lyra Therapeutics, Inc. shares climbed 33.3% to $5.78 as the company reported a price placement for gross proceeds of $110.5 million.

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell.

The average RUBY stock price target is 21.00 with a high estimate of 40.00 and a low estimate of 5.00.

About RUBY. Rubius Therapeutics Inc is a clinical-stage biopharmaceutical company.

Its RED PLATFORM is designed to genetically engineer, and culture Red Cell Therapeutics that are ready-to-use cellular therapies for the treatment of cancer and autoimmune diseases.

Webull offers kinds of Rubius Therapeutics Inc stock information, including NASDAQ:RUBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RUBY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RUBY stock methods without spending real money on the virtual paper trading platform.

Rubius Therapeutics, Inc. Stock Price, Quote & News

Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial of RTX-224, a Broad Immune Agonist, for the …. CAMBRIDGE, Mass., Jan. 13, 2022 – Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an ent…. 2 months ago – GlobeNewsWire.

CAMBRIDGE, Mass., Dec. 01, 2021 – Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an enti…. 4 months ago – GlobeNewsWire.

Rubius Therapeutics Inc [RUBY] Stock

Best responses include partial responses in certain patients with non-small cell lung cancer, metastatic anal cancer and metastatic uveal melanoma with no treatment-related grade 3/4 adverse events or dose-limiting toxicities as of the cutoff date.

First patient dosed in phase 1/2 clinical trial of rtx-224 in patients with certain advanced solid tumors in january 2022 single-agent phase 1 rtx-240 clinical trial in advanced solid tumors continues with no dose-limiting toxicities observed to date and an nk cell dose response.

A clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called red cell therapeutics™ for the treatment of cancer and autoimmune disease, today announced that the first patient has been dosed in its phase 1/2 clinical trial of rtx-224 for the treatment of patients with certain relapsed/refractory or locally advanced solid tumors, including non-small cell lung cancer, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial carcinoma and triple-negative breast cancer.

Continuing dose escalation in single-agent phase 1 rtx-240 clinical trial in advanced solid tumors with no dose-limiting toxicities observed to date and an nk cell dose response with clinical results expected in q1’22.

Highly versatile and programmable red platform enables multiple modalities to target different immune pathways across a range of diseases.

CAMBRIDGE, Mass., Sept. 01, 2021 – Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced that the Company’s executive management team will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 9-13, 2021, and the H.C. Wainwright 23rd Annual Global Investment Conference on September 14, 2021.

Users should not base their investment decision upon “JimStromberg.com”.

ScienceDirect Topics

95 In three different clinical trials, tiotropium reduced COPD exacerbations between 22% and 31%. Although these results suggest similar clinical responses for all of these agents, an important consideration for an individual patient is the inhalation device and the patient’s ability to master it.

With the carbapenem class antibiotic agents, a large multicenter clinical trial proved imipenem therapy superior to aminoglycoside and a macrolide antibiotic, with survival demonstrably superior only in the patients with the highest acute physiology and chronic health evaluation scores.

Multiple studies have suggested that inappropriate initial therapy increases mortality risk.110,111 Initiating two gram-negative agents rather than one increases the likelihood that initial therapy will include an active agent, which in turn is associated with lower mortality risk.195-199 There are no differences in clinical outcomes between patients receiving definitive therapy with one versus two active agents once susceptibilities are available.

Traditional head-to-head monotherapy studies are unlikely to demonstrate superiority of a novel drug over an established agent at equivalent doses without recruiting an impractical number of patients.

Withdrawal to monotherapy studies are ethically dubious; these studies often do not provide efficacy as monotherapy, and include a patient population different from that in which the new AED will subsequently be licensed.

238 Meta-analyses of studies involving 2717 patients comparing monotherapy with various antiandrogens suggested that the hazard ratio for recurrence was greater with antiandrogen monotherapy than with medical or surgical castration, but statistical significance was approached but not reached.

In patients with new-onset epilepsy the motivation to tolerate mild adverse effects is usually very poor compared with patients with medically refractory epilepsy.

Definition Of Monotherapy By Medical Dictionary

The treatment of a medical disorder with a single drug.

A type or instance of such treatment: evaluating antimalarial monotherapies.

Monotherapy Single drug therapy or treatment Therapeutics The management of a particular condition-eg, HTN, with a single agent.

What Does MONOTHERAPY Mean?

0.00 / 0 votes)Rate this definition:monotherapynoun.

The numerical value of MONOTHERAPY in Chaldean Numerology is: 4.Pythagorean Numerology.

The numerical value of MONOTHERAPY in Pythagorean Numerology is: 6.

Monotherapy In The Treatment Of Hypertension

Approximately 600 people with mild to moderate hypertension were treated with a regimen that started with monotherapy.

Reduction in sodium intake achieved adequate blood pressure control in 38 percent, higher than that achieved without therapy.

When initial blood pressure was greater than 110 mm Hg, satisfactory control was achieved in fewer patients; in this group, therapy with reduction of sodium intake alone is rarely effective.

All measures were about equally successful in treating isolated systolic hypertension.

The group given thiazide diuretics alone had an increased number of deaths from myocardial infarcts compared with other groups.

This was not seen if a beta-blocking drug or a centrally-acting drug was used in conjunction with the thiazide diuretic.

Monotherapy can successfully reduce blood pressure in most patients with mild hypertension.

Combination Therapy

Combination therapy or polytherapy is therapy that uses more than one medication or modality.

‘Pharmaceutical’ combination therapy may be achieved by prescribing/administering separate drugs, or, where available, dosage forms that contain more than one active ingredient.

Sometimes “Polymedicine” is used to refer to pharmaceutical combination therapy.

Conditions treated with combination therapy include tuberculosis, leprosy, cancer, malaria, and HIV/AIDS. One major benefit of combination therapies is that they reduce development of drug resistance since a pathogen or tumor is less likely to have resistance to multiple drugs simultaneously.

Combination therapy may seem costlier than monotherapy in the short term, but when it is used appropriately, it causes significant savings: lower treatment failure rate, lower case-fatality ratios, fewer side-effects than monotherapy, slower development of resistance, and thus less money needed for the development of new drugs.

Combination therapy has gained momentum in oncology in recent years, with various studies demonstrating higher response rates with combinations of drugs compared to monotherapies, and the FDA recently approving therapeutic combination regimens that demonstrated superior safety and efficacy to monotherapies.

Combination therapy with two or more antibiotics are often used in an effort to treat multi-drug resistant Gram-negative bacteria.

Education Requirements & Job Details

Sonographers with multiple certifications will have even more job opportunities.

Accreditation information can be found at the Commission on Accreditation of Allied Health Education Programs and the Joint Review Committee on Education in Diagnostic Medical Sonography.

Many two-year colleges offer an associate degree program, which often follows completion of an X-ray or other allied health program.

If a student already has some healthcare education and experience, there are 12 to 15 month ultrasound-specific programs, often university- or hospital-based.

In some US states, sonographers can only practice ultrasound if they have a license that proves they graduated with a certificate from an ultrasound program.

Beginning in 2018, the quickest way to become certified will be to complete a certificate program in diagnostic medical sonography accredited by the Commission on Accreditation of Allied Health Education Programs.

Some associate degree programs have transfer agreements with bachelor’s programs in sonography.

How To Become A Sonographer

What is the difference between a sonographer and an ultrasound technician?

How to Become an Obstetric and Gynecological Sonographer What is obstetric and gynecological ultrasound?

How to get certified in obstetric and gynecological ultrasound?

A type of echo called Doppler ultrasound shows how well blood flows through your heart’s chambers and valves.

How to become a Vascular Sonographer What is vascular ultrasound?

How to become a Musculoskeletal Sonographer What is musculoskeletal ultrasound?

How to get certified in musculoskeletal ultrasound?

Requirements To Become A Sonographer

Why would someone want to become a sonographer? There are many reasons why this is a desirable career path.

According to the Society of Diagnostic Medical Sonography, sonographers enjoy working as an integral member of a larger healthcare team, creating high-tech images to aid physicians and doctors in diagnosing illnesses, and working one-on-one with healthy and seriously ill patients.

Medical sonographers use a variety of tools to create images of specific parts of the body, including organs and tissues, which may include the abdomen, blood vessels, breasts, heart, and female reproductive systems, according to the SDMS. These images can be important in detecting a variety of diseases, including heart and vascular disease, which according to the Centers for Disease Control is the leading cause of death in the United States.

Some of the technologies sonographers use on the job range from A-Mode ultrasound machines to pulsed-wave Doppler ultrasound units, according to O*NET. They also typically use a small tool called a transducer that is placed upon a patient’s skin in the area to be imaged.

After students have completed a sonography program, they can prepare to work toward sonographer certification.

By comparison, the ARDMS offers five different certification credentials, ranging from registered diagnostic medical sonographer to registered vascular technologist.

As for sonographer licensing, states may also have specific requirements.

What Does A Sonographer Do??

In this article, we explain what a sonographer is, what a sonographer does, types of sonography jobs and how to become a sonographer.

What does a sonographer do? What a sonographer does is a complex job with many responsibilities related to performing ultrasounds and dealing with patients.

A vascular technologist creates images of blood vessels and an obstetric and gynaecological sonographer takes images of the female reproductive system.

Average salaries for a sonographer The average national salary of a sonographer is €52,827 per year.

How to become a sonographer Becoming a sonographer may take several years of education, experience and skill development.

Attention to detail: Being a sonographer involves taking images and being able to identify small details in those images.

Benefits of becoming a sonographer Being a sonographer can be an interesting and fulfilling job.

Mayo Clinic College Of Medicine & Science

A diagnostic medical sonographer, also known simply as a sonographer, uses imaging equipment and soundwaves to form images of many parts of the body, known as ultrasounds.

While some employers may want specialized sonographers, many general sonographer positions will require imaging experience in several of these areas.

Diagnostic medical sonographers are often found performing ultrasound procedures at a patient’s bedside, but also may work with imaging machines in a dedicated room within the hospital or clinic.

While diagnostic medical sonographers work predominantly in hospitals, they can also be employed in doctors’ offices and medical and diagnostic labs.

There are several organizations that offer certification for sonographers, including the American Registry for Diagnostic Medical Sonographers, Cardiovascular Credentialing International, and American Registry of Radiologic Technologists.

Most certified diagnostic medical sonographers will practice under the title, registered diagnostic medical sonographer, which some will also receive advanced certifications.

With additional training and education, some sonographers may move into supervisory positions or become an advanced sonographer.

Sonographer: What Is It? And How To Become One?

Table of Contents What Does a Sonographer Do? A sonographer administers ultrasounds.

The sonographer sets up the sonography equipment, performs the diagnostic ultrasound, then shares the findings with the physician.

In most cases, the sonographer will also communicate the findings to the patient.

To become a sonographer, earn a high school diploma or GED certificate.

Another path you can take to become a sonographer is to earn an associate of applied science in diagnostic medical sonography, then build on your education to advance your sonography career.

Remember, every employer is different and each will have unique qualifications when they hire for a Sonographer role.

The obstetrics and gynecology department of our medical clinic is looking for a qualified Sonographer to join our team.

How To Become A Sonographer Or Ultrasound Tech: A Careers Guide

People who want to pursue sonography need to understand exactly what sonography means and where the terms ultrasound and sonogram come into play.

Ultrasound: An ultrasound machine uses high-frequency sound waves to produce an image – referred to as a sonogram – of tissues, organs, and blood vessels.

The person operating an ultrasound machine is often referred to as an “Ultrasound tech”.

Choose a school that is certified in teaching ultrasound technology to get the best possible training in sonography.

Sonography programs provide both theoretical and hands-on training, which allows students to develop a solid foundation to build their careers on.

Students may be required to take a case study course that reviews how patient histories and sonography results are presented.

How would you explain the ultrasound process to a patient who has never had one before?

Low Temperature Co-Fired Ceramics

Low Temperature Co-Fired Ceramics SubstratesLTCC is the cost-effective and upgraded version of HTCC with firing temperatures in the range of 700-960°C. Likewise, HTCC conventional tape casting is the processing of LTCC substrates.

LTCC offers functionality such as high/low permittivity, low dielectric loss in a single multilayer package and multi-functional features by integration and interconnections.

Among these methods, low melting point glass addition is conventionally used for the fabrication of LTCC. Sebastian et al.

The subclasses of LTCC are glass-free LTCC, glass bonded ceramics, glass-ceramic composites and glass ceramics.

Although the first challenge in the development of LTCC compositions is to decrease the sintering temperature close to 900 °C, the work itself is far more complicated when commercial products for industrial purposes are targeted.

10.3.2 Low temperature co-fired ceramic MEMSThe use of LTCC to fabricate microstructures is an established process, with the first devices being demonstrated in the late 1990s.

These are fired in air for 30 minutes at 500 °C and then 20 minutes at 850 °C, which hardens the LTCC and fires the ink.

Co-Fired Ceramic

Integrated circuit package made out of fired ceramic material.

Co-fired ceramic devices are monolithic, ceramic microelectronic devices where the entire ceramic support structure and any conductive, resistive, and dielectric materials are fired in a kiln at the same time.

Co-fired ceramic devices are fabricated using a multilayer approach.

The starting material is composite green tapes, consisting of ceramic particles mixed with polymer binders.

Individual tapes are then bonded together in a lamination procedure before the devices are fired in a kiln, where the polymer part of the tape is combusted and the ceramic particles sinter together, forming a hard and dense ceramic component.

Inductors are formed by printing conductor windings on ferrite ceramic tape.

Low-temperature co-firing technology presents advantages compared to other packaging technologies including high temperature co-firing: the ceramic is generally fired below 1,000 °C due to a special composition of the material.

Low Temperature Co-Fired Ceramic

APITech’s LTCC is an alternative glass-ceramic multilayer substrate medium that incorporates conventional thick-film-material metal systems, providing a rugged, cost competitive substrate that can incorporate embedded passive components, along with more advanced devices such as flipchips and wire bonded bare die.

Overview High performance electronic packaging and substrate technology.

Specialist Substrates Tapes: range of dielectric materials providing low cost high performance and low loss characteristics.

High density, through embedded passives and bare semiconductor die.

LTCC Advantages Over Organic PCB Higher operating temperature up to 350ºC. Lower expansion coefficient.

Higher integration density: Embedded passives and higher layer count possible.

LTCC Advantages Over Thick Film Cavities and high number of layers.

Low Temp Co-Fired Ceramic Materials

Extreme heat and other harsh environments can push electronic solutions to their limits.

Advanced ceramic materials by DuPont are designed to withstand the toughest conditions and enable smaller, more reliable electronics.

DuPont LTCC material systems combine the benefits of multi-layer ceramic and thick film technologies to meet the increasing demand for electronics functioning in extreme temperatures and other harsh environments.

LTCC’s low loss characteristics make it an ideal choice for high frequency applications and enable more efficient circuits.

The DuPont line of LTCC materials provides superior performance in applications as diverse as military radar, imaging systems, advanced automotive sensing, telecommunications, and satellites.

Custom Ceramic Package Solutions In Chattanooga, TN

Crystal/Oscillator/SAW Packages AdTech Ceramics manufactures custom designed packages specifically for crystal/oscillator/SAW frequency control devices.

Optoelectronic Packages We offer custom-designed ceramic packages for CMOS, CCD, infrared and ultraviolet image sensors.

Hermetic/High Frequency Feedthroughs AdTech Ceramics specializes in hermetic ceramic feedthroughs for DC to Ka band applications.

Ceramic/Metal Packages AdTech Ceramics’ extensive experience with metal machining combined with multi-layer co-fire ceramics brazing technology provides an avenue for complex hermetic packaging applications.

Pin Grid Arrays Custom Ceramic Pin Grid Array packaging for semiconductor microprocessors as well as high temperature, optoelectronic and multichip modules applications.

Multichip Modules Utilizing multi-layer co-fired ceramics and metal components, AdTech Ceramics specializes in manufacturing custom Multichip Modules in a variety of hermetic package configurations.

Leadless Chip Carriers Our custom-made ceramic leadless chip carriers are suited for applications that warrant a surface mounted low profile package having low inductance.

Low-Temperature Co-Fired Ceramic Substrate Market Future Challenges And Industry Growth Outlook 2026

The latest research report on Low-Temperature Co-Fired Ceramic Substrate market entails a detailed assessment of the trends swaying the industry dynamics over the estimated timeline.

The product landscape of the Low-Temperature Co-Fired Ceramic Substrate market is categorized into RF System Level Package,Optoelectronic Package,Array Package andOther.

Information regarding market share, growth rate, and production patterns of each product type is given in the report.

The application ambit of the Low-Temperature Co-Fired Ceramic Substrate market is categorized into Consumer Electronics,Home Appliances,Computers and Peripherals,Automotive,Other, ,Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5: ,United States ,Europe ,China ,Japan andIndia.

Market share obtained by each application along with their growth rates over the projected timeline are elucidated in the report.

It provides a technological growth map over time to understand the market growth rate.

To conclude, Low-Temperature Co-Fired Ceramic Substrate Industry report mentions the key geographies, market landscapes alongside the product price, revenue, volume, production, supply, demand, market growth rate, and forecast, etc.

Leading Players – Murata, Kyocera, TDK, Taiyo Yuden, KOA Corporation, Yokowo, Hitachi Metals, NIKKO, Soshin Electric, Bosch – FortBendNow

New Jersey, United States – The research study on the Co-fired Ceramic Market offers you detailed and accurate analyzes to strengthen your position in the market.

The market segmentation analysis offered in the research study demonstrates how different product segments, applications, and regions are performing in the Co-fired Ceramic market.

Leading companies are profiled based on various factors including markets served, production, revenue, market share, recent developments, and gross margin.

Market players can use the qualitative and quantitative analysis provided in the report to get a good understanding of the Co-fired Ceramic market and make strong strides in the industry in terms of growth.

Which are the five top players in the Co-fired Ceramic market?

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market.

Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients.

Michael Rousseau Biography, Age, Wiki, Family, Wife, Net Worth

Michael Rousseau Early Life Michael Rousseau was born in 1958-1959 in Montreal, Canada, and in 2021 her age is 62 years.

Michael Rousseau Personal Life Michael Rousseau hasn’t revealed anything about his life partner and he hasn’t revealed his wife’s name.

Michael Rousseau Education Qualification Michael Rousseau completed his school and college studies in Canada.

Michael Rousseau Family Michael Rousseau was born in 1958-1959 in Montreal, Canada in a middle class family.

Michael Rousseau Height And Weight Michael Rousseau’s Height is approx 5 feet 8 inches, In centimeters it’s TBA, In meters, it’s TBA and Michael Rousseau’s Weight is approx 75 kg, In pounds it’s TBA. His Eye Color is Brown and his Hair Color is white.

Michael Rousseau Marital Status Michael Rousseau’s marital status is married but he hasn’t revealed anything about his wife and family, he also has children.

Michael Rousseau was born in 1958-1959, as of 2021 Michael Rousseau’s age is 62 years.

Complaints About Air Canada CEO’S English Speech Justified, Languages Commissioner Finds

A preliminary report from the Commissioner of Official Languages says complaints about a predominantly English speech by Air Canada’s CEO last fall – that allege the speech didn’t meet the airline’s obligations under the Official Languages Act – were founded.

Air Canada CEO Michael Rousseau sparked an outcry last November when, following a 26-minute speech in English that included about 20 seconds of French, he told reporters he didn’t need to learn French to live in Montreal for 14 years.

As of Feb. 28, the Office of the Commissioner of Official Languages had received 2,680 complaints about Rousseau’s Nov. 3 speech to the Montreal chamber of commerce – the most complaints ever received by the office in a single case.

In response, Air Canada said Rousseau’s remarks had been misinterpreted and the complaints should have been dismissed by the Office of the Commissioner, since the speech was made during a private activity.

French and English text versions of the speech were given to the chamber’s communications representative, and Air Canada claims also to have simultaneously posted French and English versions of the speech on its website, but did not specify when, according to the report.

Air Canada occupies a special place in Canadian society, he wrote, adding the events of Nov. 3 caused harm to the status of French in Canada.

The commissioner also recommends adding specific and measurable official language performance objectives to the performance evaluations of all senior leaders, and asks Air Canada to update the commissioner’s office on initiatives undertaken to strengthen official languages practices.

Quebec Language Watchdog Finds Complaints About Air Canada CEO Speech In English Were Founded

The Commissioner of Official Languages says a preliminary report into whether a speech by the chief executive of Air Canada in November met the airline’s obligations under the Official Languages Act has established that the complaints are founded.

Raymond Theberge notes that the conclusions are not final and that the parties involved will have the chance to provide comment before the final report.

Air Canada CEO Michael Rousseau sparked an outcry last year when, following a speech almost entirely in English, he told reporters he did not need to learn French to get by in Montreal.

He later apologized and has since started taking French lessons.

The Office of the Commissioner of Official Languages received 2,680 complaints as of Feb. 28 about the speech to make it the most complaints ever received for a single case.

Theberge said in his statement that bilingualism is a crucial skill for leaders, especially those in institutions subject to the Official Languages Act.

Preliminary Report Finds Complaints About Air Canada CEO Speech Founded: Commissioner

The Commissioner of Official Languages says a preliminary report into whether a speech by the chief executive of Air Canada in November met the airline’s obligations under the Official Languages Act has established that the complaints are founded.

Raymond Théberge notes that the conclusions are not final and that the parties involved will have the chance to provide comment before the final report.

Air Canada CEO Michael Rousseau sparked an outcry last year when, following a speech almost entirely in English, he told reporters he did not need to learn French to get by in Montreal.

He later apologized and has since started taking French lessons.

The Office of the Commissioner of Official Languages received 2,680 complaints as of Feb. 28 about the speech to make it the most complaints ever received for a single case.

Théberge said in his statement that bilingualism is a crucial skill for leaders, especially those in institutions subject to the Official Languages Act.

This report by The Canadian Press was first published April 8, 2022.

Canadian Club Toronto

Join Canadian Club Toronto on October 7 when Michael Rousseau, President and CEO of Air Canada, speaks about the airline’s path to recovery from COVID-19 and the re-building of the company and the air transport sector.

As Deputy Chief Executive Officer and Chief Financial Officer, Mr. Rousseau had oversight for several significant corporate initiatives and businesses including Air Canada Rouge, in addition to his responsibilities for the airline’s overall financial strategic direction comprising all aspects of financial reporting and planning, investor relations, treasury and controller’s operations, taxation, pension administration, internal audit, procurement and corporate real estate.

From 2007 to 2018, Mr. Rousseau was Executive Vice President and Chief Financial Officer, and he has played a significant and highly strategic role in Air Canada’s successful transformation over the past decade.

Prior to Air Canada, Mr. Rousseau held executive positions including those of President, and before that Executive Vice President and Chief Financial Officer at Canada’s largest diversified general merchandise retailer, Hudson’s Bay Company.

Mr. Rousseau has been a member of the Board of Directors at Resolute Forest Products since 2010 and he has held several Board memberships of other public companies over the past 1.8 years.

One lucky in person guest will win 2 Economy Class round trip promotional tickets for travel to the destination of their choice in Air Canada’s worldwide network.

This door prize is generously donated by Air Canada.

Air Canada CEO Debut A PR Disaster Following Comments On French, Say Experts

Air Canada’s new chief executive ignited a PR disaster by his inept handling about the French language that could have repercussions for the airline as it attempts to get back on its feet from the COVID-19 pandemic, say public relations experts.

“I can’t remember a more tone deaf and ham-fisted handling of a new CEO’s debut on the public stage than this,” said Bob Pickard, a veteran public relations expert and principal at Signal Leadership Communication Inc. While former Air Canada chief financial officer Michael Rousseau may be very capable, Pickard said his maiden speech as CEO Wednesday – almost entirely in English, his defensive response to reporters and then unsatisfactory apology – demonstrate a failure of emotional, cultural, communications and social intelligence.

Instead, he showed great disrespect to Air Canada employees and customers, especially by releasing an apology on the company’s website instead of a personal video where he tried to strike the right chord of contrition, Pickard said in an interview.

He said Rousseau should be ashamed for boasting that his mother and wife speak French while never learning the language.

A spokesperson for the commissioner of official languages says more than 1,000 complaints about Air Canada have been filed since the incident on Wednesday afternoon.

Public relations expert Jason Patuano, senior director of public relations firm TACT, said Rousseau’s lack of sensitivity could have a ripple effect on the airline, just as United Airlines faced a couple of years ago when its removal of a passenger from one of its flights went viral and had a large impact on the value of its stock.

Air Canada’s shares climbed 6.1 per cent as the Toronto Stock Exchange set new record highs.

Michael B. Rousseau, M.D.

Dr. Rousseau graduated from the University of British Columbia in 1990 and received his surgical and urology training at the University of Cincinnati Medical Center.

Dr. Rousseau is certified by the American Board of Urology and licensed in the state of Ohio.

He is a member of the American Urological Association, the American Association of Clinical Urologists and the Large Urology Group Practice Association.

Dr. Rousseau is also a member of the Ohio State Medical Association, the Society for Urodynamics and Female Urology and the National Association for Continence.

Raymond Théberge

Raymond Théberge is the ninth President and Vice-Chancellor of the Université de Moncton from June 1, 2012, to January 26, 2018, and the Commissioner of Official Languages of Canada since January 29, 2018.

In 1997, Raymond Théberge was appointed Dean of the Faculty of Education at the Université de Saint-Boniface, a position he held until 2003.

Raymond Théberge has authored more than 20 peer-reviewed publications, 84 papers and presentations, three books, a bibliography and 45 research projects on education, community, communication, culture and economics.

Raymond Théberge then entered the Canadian public service as a senior official.

Raymond Théberge has been a member of the Board of the UNESCO International Bureau of Education, and a member of the Working Group for the Preparation of the International Conference education.

Raymond Théberge also chaired the following institutions: the Council of the Deans and Directors of Education in Manitoba, the Manitoba Teacher Education and Teaching Certification Committee, the Departmental Task Force on Teacher Shortages in Manitoba, and the Francophone Association of Deans and Directors of Education in Canada.

In an official statement, Théberge addressed a perception of nominations to high offices in Canada.

Office Of The Commissioner Of Official Languages

He held a number of leadership positions before coming to the Office of the Commissioner of Official Languages, and he has significant experience with official language minority communities.

Ghislaine Saikaley, a native of Rouyn-Noranda, Quebec, joined the Office of the Commissioner of Official Languages in 2008 as Assistant Commissioner of the Compliance Assurance Branch.

During her tenure, the government presented its Action Plan for Official Languages 2003-2008, and the Official Languages Act was amended in 2005.

Wearing the emblem of the Office of the Commissioner of Official Languages shows our commitment to fostering harmony between the English and French fibres of Canada’s social fabric.

In his first report, Commissioner Fortier called for a re-launch of the official languages program, based on an in-depth review of the 1969 Official Languages Act.

Commissioner Yalden ended his term by speaking of the need to review the 1969 Official Languages Act so as to ensure its compliance with the language provisions of the Canadian Charter of Rights and Freedoms.

Spicer established the Office of the Commissioner of Official Languages during his first year as Commissioner.

Prime Minister Of Canada

Raymond Théberge holds a Ph.D. in Linguistics from McGill University.

Mr. Théberge has proudly served official language minority communities throughout his career, including as a dedicated advocate for Acadian communities.

In June 2012, Mr. Théberge was named the ninth President and Vice-Chancellor of the Université de Moncton, the largest francophone university in Canada outside of the province of Quebec.

Mr. Théberge held a number of positions in post-secondary teaching, research, and administration between 1985 and 2003, including senior positions at the Université de Saint-Boniface and the Centre d’études franco-canadiennes de l’Ouest.

Mr. Théberge has also gained extensive experience as a senior executive in the public service.

Mr. Théberge has also served as Director General of the Société franco-manitobaine, which advocates on behalf of the French-speaking community in Manitoba.

Mr. Théberge’s experience and numerous publications are a testament to his deep understanding of, and passion for, issues affecting minority language communities.

Quebec Language Watchdog Finds Complaints About Air Canada CEO Speech In English Were Founded

The Commissioner of Official Languages says a preliminary report into whether a speech by the chief executive of Air Canada in November met the airline’s obligations under the Official Languages Act has established that the complaints are founded.

Raymond Theberge notes that the conclusions are not final and that the parties involved will have the chance to provide comment before the final report.

Air Canada CEO Michael Rousseau sparked an outcry last year when, following a speech almost entirely in English, he told reporters he did not need to learn French to get by in Montreal.

He later apologized and has since started taking French lessons.

The Office of the Commissioner of Official Languages received 2,680 complaints as of Feb. 28 about the speech to make it the most complaints ever received for a single case.

Theberge said in his statement that bilingualism is a crucial skill for leaders, especially those in institutions subject to the Official Languages Act.

Preliminary Report Finds Complaints About Air Canada CEO Speech Founded: Commissioner

The Commissioner of Official Languages says a preliminary report into whether a speech by the chief executive of Air Canada in November met the airline’s obligations under the Official Languages Act has established that the complaints are founded.

Raymond Théberge notes that the conclusions are not final and that the parties involved will have the chance to provide comment before the final report.

Air Canada CEO Michael Rousseau sparked an outcry last year when, following a speech almost entirely in English, he told reporters he did not need to learn French to get by in Montreal.

He later apologized and has since started taking French lessons.

The Office of the Commissioner of Official Languages received 2,680 complaints as of Feb. 28 about the speech to make it the most complaints ever received for a single case.

Théberge said in his statement that bilingualism is a crucial skill for leaders, especially those in institutions subject to the Official Languages Act.

This report by The Canadian Press was first published April 8, 2022.

Plaintes Contre Michael Rousseau Fondées Selon Le Commissaire Aux Langues Officielles

OTTAWA – Le rapport préliminaire du commissaire aux langues officielles, Raymond Théberge, sur les plaintes portant sur un discours livré essentiellement en anglais Montréal le 3 novembre dernier par le président-directeur général d’Air Canada, Michael Rousseau, révèle que ces plaintes sont fondées.

L’enquête du commissaire vise déterminer si Air Canada a manqué ses obligations prévues la Loi sur les langues officielles lors de ce discours.

Raymond Théberge rappelle ce stade de son travail que le bilinguisme est une compétence cruciale pour tout chef de file, particulièrement pour ceux des institutions assujetties la Loi.

En date du 28 février dernier, le commissaire a reçu 2680 plaintes ce sujet, le nombre le plus élevé dans l’histoire du Commissariat, selon M. Théberge.

Le rapport préliminaire d’enquête a été envoyé aux plaignants et Air Canada, pour commentaires.

Lorsque ceux-ci auront été recueillis et analysés, le rapport final d’enquête sera préparé puis envoyé aux parties.

Entreprise citée dans cette dépêche: Air Canada.

First-Degree Murder Charge Laid In Red Deer Fire

A woman and a man were hospitalized after a residential fire in Red Deer last Thursday.

The woman died and the man survived, but he was charged with first-degree murder.

Mounties responded to a fire in a basement suite on 39 Street in the West Park neighbourhood at around 3:30 a.m. Two people were taken to hospital with life-threatening injuries but the 21-year-old woman died.

Raymond Richard, 37, was released and charged with first-degree murder and arson, police said.

The Red Deer man is in custody and scheduled to appear in court Thursday.

The cause of the woman’s death will not be released, RCMP said.

2022 Bolt EV: Electric Car

CHARGING MADE EASY. Charging your vehicle is as simple as plugging in your smartphone.

Whether it’s charging your vehicle or utilizing a network of over 40,000 public stations, Chevrolet provides the tools to ensure a convenient experience.

CHEVY SAFETY ASSIST. 2022 Bolt EV comes standard with Chevy Safety Assist – a suite of our advanced safety features designed to let you go confidently ahead. Safety or driver assistance features are no substitute for the driver’s responsibility to operate the vehicle in a safe manner.

The driver should remain attentive to traffic, surroundings and road conditions at all times.

Visibility, weather and road conditions may affect feature performance.

Read the vehicle Owner’s Manual for more important feature limitations and information.

If you want to determine whether or not there is a recall on your current vehicle or on a vehicle you are considering, visit www.

2022 Chevrolet Bolt EV Review, Pricing, And Specs

Overview The 2022 Chevy Bolt EV not only looks more exciting inside and out, the redesigned electric hatchback also has enhanced features and a much cheaper asking price.

Chevy estimates the 2022 Bolt EV can travel up to 259 miles on a full charge.

What’s New for 2022?The 2022 Bolt EV undergoes a comprehensive redesign that includes updated exterior and interior styling.

Pricing and Which One to Buy Chevy has announced that the 2022 Bolt EV’s base price is significantly lower than last year, but so far it hasn’t revealed pricing for individual options or higher trim levels.

EV Motor, Power, and PerformanceAlthough we have not driven the 2022 Bolt EV, its powertrain and chassis are identical to older models that we have piloted.

For 2022, the Bolt EV is now available with a dual-level charging cord that plugs into both Level 1 and Level 2 outlets, which Chevy says will eliminate the need for many owners to buy a separate home charger.

How to Buy and Maintain a Car.Safety and Driver-Assistance FeaturesThe 2022 Bolt EV boasts a roster of standard and optional driver-assistance technology.

GM Hits Reset Button With The Chevrolet Bolt, Kicks Off New Ad Campaign

General Motors is set to launch a new ad campaign to regain customers’ trust in the Chevrolet Bolt EV and EUV, which were plagued with an expensive battery recall and production halts for more than a year.

In 2021, multiple reports of battery fires led GM to issue a massive recall for any Bolt EV made since the start of production in 2017.

When asked what consumers should consider when thinking about purchasing a Bolt and its past battery issues, Balch said that the Bolt represents a focus on gaining consumer trust and a good entry point for drivers thinking about switching to an all-electric experience.

The 2022 Chevrolet Bolt EUV features the company’s hands-free Super Cruise driving modes on certain highways.

The 2022 Chevrolet Bolt EUV has a bigger passenger compartment than the Bolt EV. Chevrolet.

GM issued production halts for the Bolt line that was prolonged until production restarted this month.

The 2022 Chevrolet Bolt EV starts at $31,500 and has an EPA-estimated range of 259 miles.

Chevy Bolt EV, Bolt EUV Regenerative Braking How To: Video

General Motors has released a video instructing owners of the Chevy Bolt EV and Bolt EUV on how to get the most out of the compact car’s standard regenerative braking system.

The Chevy Bolt EV and Bolt EUV both feature on-demand regenerative braking that is controlled via the steering wheel-mounted paddles.

The Chevy Bolt EV and Bolt EUV also feature seamless regenerative braking when in the standard ‘Drive’ mode, which will use a smaller amount of regenerative braking to slow the vehicle when the driver lifts off the accelerator pedal, without them having to pull the steering wheel paddle.

The user can adjust the strength of the automatic regenerative braking, with four regenerative braking levels to choose from.

The Bolt EV and Bolt EUV also feature one-pedal driving, which allows the user to rapidly slow the vehicle by simply lifting off the accelerator.

While the only Chevy models it’s currently offered on are the Chevy Bolt EV and Bolt EUV, similar regenerative braking control systems will likely appear in the Chevy Equinox EV, Chevy Silverado EV and other future EV models from the brand.

Power in the Chevy Bolt EV and Bolt EUV comes from a single, front axle-mounted electric motor rated at 201 horsepower and 266 pound-feet of torque, which receives energy from a 65 kWh lithium-ion battery.

Chevrolet Bolt

The Chevrolet Bolt or Chevrolet Bolt EV is a battery electric subcompact hatchback produced by General Motors under the Chevrolet marque.

In January 2016, at the Consumer Electronics Show in Las Vegas, the production version of the Chevrolet Bolt was unveiled.

As a precautionary measure, Chevrolet issued software updates that allow dealers to install a battery charge limit of 90% to their existing inventory while urging current 2017-2019 Chevy Bolt owners to enable the “Hill Top Reserve” option or to set vehicle “Target Charge Level” to 90%. A final software update was expected to remedy the charging capacity to 100% sometime in April 2021.

On August 20, 2021 Chevrolet extended the recall to include all Bolt models and model years totaling the number of recalled Chevy Bolt cars to nearly 142,000.

While initially expected to share its lithium-ion battery technology with the second generation Chevrolet Volt, the production version of the Bolt uses batteries with a different chemistry more suited to the different charge cycles of a long-range electric vehicle, compared to the more frequent charging/discharging of hybrids and short-range EVs.

Sales totaled 23,297 units in 2017, making the Bolt the U.S. second best selling plug-in car in 2017 after the Tesla Model S. In California, the Bolt listed as the top selling plug-in car with 13,487 units delivered, ahead of the much more expensive Tesla Model S, listed second with 11,813.

In 2015, Chevrolet acknowledged confusion between two vehicles with a similar-sounding names; Bolt and Volt.

2022 Chevrolet Bolt Pros And Cons Review: Edgier But Still Sensible

The Chevrolet Bolt was our 2017 Car of the Year-is the 2022 refresh enough to win the title again?

For the 2022 model year, Chevy gave the Bolt a needed update to compete with an exploding number of new EVs, hoping new clothes on the old emperor would be enough to win the title again.

The Bolt is an affordable commuter car with a range of 259 miles from its 65-kWh battery, which is competitive for its segment.

“I’m continually impressed with how fun the Bolt is to drive,” features editor Christian Seabaugh said.

The updated Bolt has better seats in a roomy interior with a push-button electric gearshift that frees up space.

Chevy dropped the price $5,500 for 2022; you can get a Bolt for $31,995.

While improved, the 2022 Bolt is not a COTY finalist.

Is The Chevy Bolt Basically Dead?

In this story, the fortune tellers are CNN and Automotive News, the entrails are GM’s statement last week regarding the $7 billion investment in EV production, much of which will be spent on the Lake Orion Assembly facility, the future being predicted is that the Chevrolet Bolt and Bolt EUV battery-electric hatchbacks are not much longer for this world.

Parallel to all of this, the Bolt has effectively been out of production since last November, when GM prioritized recalling and replacing all the battery packs in all the Bolts ever produced.

When CNN asked GM about the car, automaker spokesman Dan Flores responded, “Production of the Chevrolet Bolt EV and EUV will continue during conversion activities to prepare the facility for production of the Silverado EV and Sierra EV pickups,” and, “We are not disclosing any additional information at this time about Bolt EV or Bolt EUV production.” Adding up all the circumstantial evidence, CNN rang the doomsday bell with, “It sure looks like GM is about to pull the plug on the Bolt.”.

AN said industry intelligence firm AutoForecast Solutions believes the Bolt will die in 2023, the Bolt EUV in 2024.

Both models are a little larger than the Bolt EUV, but the Ultium internals and $30,000 price would make the new crossovers more advanced than the Bolt for less dosh than the Bolt.

A Bloomberg Quint piece thinks CNN and AN are jumping the gun, suggesting that GM could transfer production to another one of its EV assembly plants coming on line, adding the left-field idea that GM could keep the car but ditch the Bolt name.

Bloomberg supports that latter take by noting that the Bolt is Chevy’s most successful conquest vehicle and gets high ownership satisfaction scores, but is a Bolt by any other name still a draw?

Ferrero SpA

Ferrero International S.A., more commonly known as Ferrero Group or simply Ferrero, is a multinational manufacturer of branded chocolate and confectionery products, and the second biggest chocolate producer and confectionery company in the world.

The company saw a period of tremendous growth and success under Pietro’s son Michele Ferrero, who in turn handed over the daily operations to his sons, Pietro Jr. and Giovanni Ferrero.

The Ferrero Group worldwide – now headed by Executive Chairman Giovanni Ferrero – includes 38 trading companies, 18 factories, and approximately 40,000 employees, and produces around 365,000 tonnes of Nutella each year.

Ferrero SA is a private company owned by the Ferrero family and has been described as “One of the world’s most secretive firms”.

With assistance from his brother Giovanni Ferrero Sr., Pietro Ferrero created his new company to produce and market the initial product.

It also produces the line of Ferrero branded chocolate products, including Pocket Coffee, Mon Chéri, Confetteria Raffaello, Ferrero Küsschen and the Ferrero Prestige line, which comprises three different brands of pralines: Ferrero Rocher, Ferrero Rondnoir, and Garden Coco.

In 1983, the company established the Ferrero Foundation in Alba, Piedmont at the wish of Michele Ferrero.

Ferrero SpA, The Company Behind Ferrero Rocher Chocolates

Company Perspectives: FERRERO TODAY. Today, Ferrero remains a true family-run success story.

A third generation of Ferrero sons have joined their father and continue to operate under the same basic principles that gave Ferrero its start in Alba over 50 years ago.

1946: Ferrero introduces his own recipe, a mixture of hazelnuts and cocoa butter called “Pasta gianduja.” 1948: Ferrero launches its own distribution operations, building up a fleet of 200 delivery vans by the early 1950s.

Still owned and run by the Ferrero family, Ferrero has built its success on a limited number of strong brands, including the hugely popular hazelnut and chocolate spread Nutella-the company claims that its spread outsells peanut butter around the world; the Kinder brand, which includes the company’s popular Kinder Surprise chocolate egg with the toy inside and other snack products; Ferrero Rocher and Mon Cheri chocolates; and Tic Tac, a world leader in breath mints.

In that year, Ferrero incorporated the company as Ferrero SpA. Joining the company were Ferrero’s brother, Giovanni, and his son, Michele.

While delivering to a Milan wholesaler Giovanni Ferrero recognized the potential for selling directly to customers-when Ferrero arrived to make his delivery, the wholesaler was closed.

Ferrero began developing its own fleet of delivery vehicles in the late 1940s, enabling the company to cut costs, while also providing a bit of added advertising by using the company’s own fleet of trucks sporting the Ferrero logo.

WikiCorporates

Ferrero International SA, parent company of the group, includes 94 companies worldwide, 25 manufacturing plants.

Date?: Pasta Gianduja, fore-runner of Nutella chocolate-hazelnut spread. Ferrara is the 3rd-largest non-chocolate confectionary company in the USA, created in 2012 when private equity firm Catterton Partners merged Ferrara Pan Candy Company Inc and Farley’s & Sathers Candy Company Inc. Headquartered in Oakbrook Terrace, Illinois, the Company specialises in gummies, seasonal candies, fruit snacks, and other general line candies, predominately in the USA. Website.

Dec.2017: #Ferrara Candy Company, maker of Red Hots and Trolli gummies, was bought from private equity firm L Catterton, as part of Ferrero’s ongoing USA market expansion plan.

Feb.2002: Farley’s & Sathers Candy Company Inc was formed by private equity firm Catterton Partners,ref to acquire assets from Kraft Foods’s sale of Favorite Brands.

1891: Farley Candy Company: Gunther Chocolate Company merged with another smaller candy company, started by another member of the Farley family.

In Nov.2016, Thorntons was re-registered as a private limited company.

Apr.1988: Thorntons plc: re-registered as a public company.

Ferrero North America Corporate Website

Ferrero North America announces innovations and initiatives across its brand portfolio at Sweets & Snacks Expo.

THE FERRERO GROUP CONTINUES TO MAKE PROGRESS ON ITS 2025 PACKAGING COMMITMENT. The Ferrero Group is making further strides in its commitment to making 100% of packaging reusable, recyclable or…. 2021-07-29.

Ferrero breaks ground on new chocolate processing facility in Bloomington, Illinois, its first ever in North America.

FERRERO MAKES VALENTINE’S DAY SWEET WITH HEARTFELT TREATS. With a range of delicious confections in lovable packaging, Ferrero brands are here to help you show your affection.

New items include delicious confections from Kinder Joy®, Ferrero Rocher®, Fannie May® and more.

FERRERO APPOINTS ALESSANDRO NATOLA AS NEW PRESIDENT OF CANADIAN BUSINESS. Natola to continue Canada’s strong momentum with new category growth, market leadership, and innovation.

Ferrero has announced two new partnerships to help tackle the sustainability challenge in North America.

List Of Ferrero Products, Variants & Flavors

Whether it may be Valentine’s Day, a normal craving day, or just for desserts, Ferrero Rocher chocolates are indeed something special to give, or better, to EAT! Ferrero Rocher is a spherical shaped chocolate with a whole roasted hazelnut enclosed in a very thin wafer cover packed with hazelnut cream and chopped hazelnuts.

Ferrero Rocher was invented by an Italian chocolatier named Ferrero SpA and was introduced in 1982.

Ferrero SpA’s other products include the very famous Nutella, Tic Tac candy, and the Kinder Surprise.

On their website, the Ferrero team shared their missions and values.

The Ferrero Group is comprised of seventy-three different joint companies handling twenty production plants that supplies mainly to over a hundred outlet markets.

Ferrero Rocher chocolates are a must-have craving of the entire world.

Here is the full list of Ferrero Rocher flavors, sizes and variants: Ferrero Mon Cheri.

Kinder Chocolates Recalled Over Salmonella Concerns

Confectionary company Ferrero has voluntarily recalled some of its Kinder chocolates from U.S. shelves because of a potential link to salmonella contamination.

The U.S. recall is for Kinder Happy Moments Milk Chocolate and Crispy Wafers Assortment and for Kinder Mix Chocolate Treats Basket, which were manufactured at a facility where Salmonella typhimurium was detected, the company said in a statement distributed by the U.S. Food and Drug Administration.

“While there are no reports of illness in the United States to date, Ferrero is voluntarily recalling the products out of an abundance of caution due to reported cases of Salmonella in consumers that consumed products in Europe that were manufactured at the same facility,” the company said.

Recalls have already spread across Europe, where several cases of salmonella-related illness have been linked back to potential contamination issues with Ferrero chocolates.

On April 2, Ferrero recalled select batches of its Kinder Surprise chocolates in the United Kingdom that were manufactured at a plant in Belgium where salmonella was detected.

Four days later, the company expanded this recall to include additional products, including certain batches of Kinder Mini Eggs, Kinder Egg Hunt Kit, and Kinder Schokobons.

For every case of salmonella that’s confirmed because somebody suspected the illness and got tested, there are usually at least another 30 people who get food poisoning and don’t go to a doctor or get tests, according to the CDC. U.S. consumers who have purchased recalled Kinder products shouldn’t eat them, and can contact Ferrero customer service at 800-688-3552 to request a refund.

Ferrero Recalls Kinder Chocolates In U.S. Over Salmonella Fears

Italian confectionery giant Ferrero said Thursday it had recalled certain varieties of its Kinder chocolates from retailers in the United States due to possible salmonella contamination.

The company said it was cooperating with the Food and Drug Administration over reported salmonella cases in Europe, announcing the precautionary recall of two chocolate varieties from three retailers in the United States.

“There are no confirmed cases in the US to date and no other Kinder or Ferrero Products are affected by this recall,” the company said in a statement.

Ferrero added that it was working closely with the retailers to ensure the products were no longer “Available for purchase.”

Salmonella is a type of bacteria that can cause symptoms including diarrhea, fever and stomach cramps in humans and is one of the most common food-borne infections.

Most cases are caused by the ingestion of food contaminated with animal or human feces.

Britain’s Food Standards Agency has said 63 cases of salmonella have been identified across the UK. In France, 21 cases have been reported and 15 reported having eaten the Kinder products that have now been recalled, according to the French public health service.

A Kinder chocolate factory in Belgium has been ordered to close after it was linked to dozens of salmonella cases.

Belgium’s food safety authority has also ordered the recall of all Kinder products made at the factory in Arlon, which is owned by Ferrero.

Suspected salmonella cases linked to Kinder chocolate have been reported in countries including the UK, Germany, France and Belgium.

Belgium’s food safety authority, the AFSCA, said the factory was ordered to shut after Ferrero was unable to provide complete information for its investigation.

On Thursday, Ferrero recalled some of its Kinder chocolates from shops in the US over concerns about potential salmonella contamination.

Some Kinder chocolates have also been recalled in parts of Asia, including Hong Kong and Singapore.

Ferrero has previously described the recalls as “Precautionary” and said none of its Kinder products released for sale had tested positive for salmonella.

Salmonella Homepage

CDC estimates Salmonella bacteria cause about 1.35 million infections, 26,500 hospitalizations, and 420 deaths in the United States every year.

Most people who get ill from Salmonella have diarrhea, fever, and stomach cramps.

Symptoms usually begin 6 hours to 6 days after infection and last 4 to 7 days.

Most people recover without specific treatment and should not take antibiotics.

Antibiotics are typically used only to treat people who have severe illness or who are at risk for it.

Some people’s illness may be so severe that they need to be hospitalized.

Salmonella Infection

Salmonella infection is a common bacterial disease that affects the intestinal tract.

Typically, people with salmonella infection have no symptoms.

In some cases, the diarrhea associated with salmonella infection can be so dehydrating as to require prompt medical attention.

Your risk of acquiring salmonella infection is higher if you travel to countries with poor sanitation.

Salmonella infection is usually caused by eating raw or undercooked meat, poultry, eggs or egg products.

Factors that may increase your risk of salmonella infection include activities that may bring you into closer contact with salmonella bacteria and health problems that may weaken your resistance to infection in general.

Salmonella infection usually isn’t life-threatening.

Salmonella

Salmonella can be spread by food handlers who do not wash their hands and/or the surfaces and tools they use between food preparation steps, and when people eat raw or undercooked foods.

People who have direct contact with certain animals, including poultry and reptiles, can spread the bacteria from the animals to food if they do not practice proper hand washing hygiene before handling food.

Pets can also spread the bacteria within the home environment if they eat food contaminated with Salmonella.

Past U.S. outbreaks of salmonellosis have been associated with meat products, poultry products, raw or undercooked eggs and dough, dairy products, fruits, leafy greens, raw sprouts, fresh vegetables, nut butters and spreads, pet foods and treats.

Wash the inside walls and shelves of the refrigerator, cutting boards and countertops, and utensils that may have contacted contaminated foods; then sanitize them with a solution of one tablespoon of chlorine bleach to one gallon of hot water; dry with a clean cloth or paper towel that has not been previously used.

People with pets should take special care to avoid cross-contamination when preparing their pet’s food.

Be sure to pick up and thoroughly wash food dishes as soon as pets are done eating, and prevent children, the elderly, and any other people with weak immune systems from handling or being exposed to the food or pets that have eaten potentially contaminated food.

Medical Microbiology

Salmonellosis ranges clinically from the common Salmonella gastroenteritis to enteric fevers which are life-threatening febrile systemic illness requiring prompt antibiotic therapy.

The septicemic form of salmonella infection can be an intermediate stage of infection in which the patient is not experiencing intestinal symptoms and the bacteria cannot be isolated from fecal specimens.

The severity of the infection and whether it remains localized in the intestine or disseminates to the bloodstream may depend on the resistance of the patient and the virulence of the Salmonella isolate.

Most serovars are killed promptly in extraintestinal sites, and the most common human Salmonella infection, gastroenteritis, remains confined to the intestine.

In AIDS, Salmonella infection is common, frequently persistent and bacteremic, and often resistant to even prolonged antibiotic treatment.

Plasmid DNA fingerprinting and bacteria phage lysotyping of Salmonella isolates are powerful epidemiologic tools for studying outbreaks of salmonellosis and tracing the spread of the organisms in the environment.

Antibiotics are not recommended for uncomplicated Salmonella gastroenteritis because they do not shorten the illness and they significantly prolong the fecal excretion of the organisms and increase the number of antibiotic-resistant strains.

Symptoms And Causes

Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell.

In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells.

Signs and symptoms of multiple myeloma can vary and, early in the disease, there may be none.

In the bone marrow, myeloma cells crowd out healthy blood cells, leading to fatigue and an inability to fight infections.

The myeloma cells continue trying to produce antibodies, as healthy plasma cells do, but the myeloma cells produce abnormal antibodies that the body can’t use.

MGUS, like multiple myeloma, is marked by the presence of M proteins – produced by abnormal plasma cells – in your blood.

As myeloma cells crowd out normal blood cells, multiple myeloma can also cause anemia and other blood problems.

Multiple Myeloma

EBV-positive multiple myeloma is classified by the World Health Organization as one form of the Epstein-Barr virus-associated lymphoproliferative diseases and termed Epstein-Barr virus-associated plasma cell myeloma.

This myeloma is characterized by a rise in the number of bone marrow plasma cells or levels of the circulating myeloma protein above that seen in MGUS. Subsequent genetic and epigenetic changes lead to a new, more aggressive clone of plasma cells, which cause further rises in the level of the circulating myeloma protein, further rises in the number of bone marrow plasma cells, or the development of one or more of a specific set of “CRAB” symptoms, which are the basis for diagnosing malignant multiple myeloma and treating the disease.

Monoclonal gammopathy of undetermined significance smoldering multiple myeloma multiple myeloma plasma cell leukemia.

Being asymptomatic, monoclonal gammopathy of undetermined significance and smoldering multiple myeloma are typically diagnosed fortuitously by detecting a myeloma protein on serum protein electrophoresis tests done for other purposes.

MGUS is a relatively stable condition afflicting 3% of people aged 50 and 5% of people aged 70; it progresses to multiple myeloma at a rate of 0.5-1% cases per year; smoldering multiple myeloma does so at a rate of 10% per year for the first 5 years, but then falls off sharply to 3% per year for the next 5 years and thereafter to 1% per year.

In theory, multiple myeloma can produce all classes of immunoglobulin, but IgG paraproteins are most common, followed by IgA and IgM. IgD and IgE myeloma are very rare.

The biomarker criteria were added so that smouldering people with multiple myeloma at high risk of developing multiple myeloma could be diagnosed before organ damage occurred, so they would therefore have a better prognosis.

Myeloma

In myeloma, the cells grow too much, crowding out normal cells in the bone marrow that make red blood cells, platelets, and other white blood cells.

Scientists don’t understand why some people get myeloma and others don’t.

Age is the most significant risk factor for developing myeloma.

Men are more likely than women to develop myeloma, and myeloma is more than twice as common among Black people as among White people.

In rare cases, exposure to X-rays or other kinds of ionizing radiation may be a risk factor for developing myeloma.

Being overweight and having obesity are linked with a higher risk of getting multiple myeloma.

When more advanced, symptoms of myeloma may include bone pain, especially in the back or ribs; bones that break easily; fever for no known reason; frequent infections; bruising or bleeding easily; trouble breathing; weakness of the arms or legs; and feeling very tired.

Multiple Myeloma: Symptoms, Causes, Diagnosis And Treatment

The plasma cells crowd out regular blood cells in your bones.

As multiple myeloma gets worse, the plasma cells spill out of your bone marrow and spread. This causes more organ damage.

Multiple myeloma is one of many conditions that can cause problems with your plasma cells.

This is like multiple myeloma, but it causes a single unusual plasma cell growth rather than many of them.

This causes unusual plasma cells in your bone marrow, but there are fewer of them than with multiple myeloma.

Monoclonal antibodies help your immune system find and destroy myeloma cells.

Stem cell transplantation often helps you live longer, but it doesn’t cure multiple myeloma, and it can cause serious complications.

Multiple Myeloma Prognosis, Symptoms, Treatment & Survival Rate

Treatment of multiple myeloma focuses on decreasing the severity of symptoms with medications, stem cell transplants, bisphosphonate therapy, platelet transfusions, and/or plasmapheresis.

What are risk factors for multiple myeloma? Is multiple myeloma hereditary?

Smoldering multiple myeloma is an early precursor to multiple myeloma.

What is the prognosis for multiple myeloma? What is the survival rate for multiple myeloma?

Experimental studies on multiple myeloma have shown that if stem cells from patients with multiple myeloma are grown in cell culture, patients can improve but could also relapse because the stem cells often were contaminated with a few multiple myeloma cells.

If stem cells for multiple myeloma patients are treated with myxoma viruses, the patient’s stem cells are not contaminated multiple myeloma cells.

Researchers have used this method to provide multiple myeloma patients with uncontaminated stem cells successfully preventing relapse of multiple myeloma due to contaminated stem cell cultures.

How Long Can I Live With Multiple Myeloma?

While multiple myeloma doesn’t yet have a cure and can be fatal, patients’ life expectancies vary widely, according to Jens Hillengass, MD, Chief of Myeloma at Roswell Park Comprehensive Cancer Center.

Multiple myeloma is a cancer of cells of the immune system which can cause symptoms like holes in the bones, kidney failure, low blood counts and high calcium in the blood.

The cancer’s spread in the body, how a patient likely will respond to treatment factors, blood levels of certain proteins and other substances, kidney function, the patient’s age and overall health – all indicate how well a patient will do during therapy.

Patients with multiple myeloma receive continuous treatments with phases of stronger and less-strong therapy, according to Dr. Hillengass,.

The Roswell Park myeloma team’s credo is: “Our team will do everything that we can to find a cure for multiple myeloma. Furthermore, it is our goal to improve your quality of life and help you to achieve milestones while on your journey, via access to cutting-edge treatment and clinical trials. Together, we can change the way the world views myeloma.”

Find out more of what makes Roswell Park unique in treating multiple myeloma.

“Dr. Hillengass says that while it is not yet certain how patients get multiple myeloma,”there are several risk factors like exposure to chemicals, for example, Agent Orange and radiation.

Multiple Myeloma: Symptoms & Treatment

Multiple myeloma is a kind of blood cancer that causes the body to produce abnormal plasma cells.

Accumulate in the bone marrow, outnumber the normal blood cells and limit your body’s ability to make healthy blood cells.

Doctors can treat symptoms and may be able to fully control the disease or slow the production of cancerous cells.

This is done to confirm the diagnosis of multiple myeloma by looking for percentage of abnormal plasma cells in the bone marrow.

Some patients with multiple myeloma need stem cell transplantation.

Stem cells are specialized cells that can develop into different types of blood cells.

The bone marrow in patients with multiple myeloma is making abnormal plasma cells in excess, instead of normal cells.

Gallium Arsenide

GaAs is often used as a substrate material for the epitaxial growth of other III-V semiconductors, including indium gallium arsenide, aluminum gallium arsenide and others.

It has a higher saturated electron velocity and higher electron mobility, allowing gallium arsenide transistors to function at frequencies in excess of 250 GHz. GaAs devices are relatively insensitive to overheating, owing to their wider energy band gap, and they also tend to create less noise in electronic circuits than silicon devices, especially at high frequencies.

In contrast, GaAs has a very high impurity density, which makes it difficult to build integrated circuits with small structures, so the 500 nm process is a common process for GaAs.

The GaAs solar cells, manufactured by Kvant, were chosen because of their higher performance in high temperature environments.

In 1970, the GaAs heterostructure solar cells were developed by the team led by Zhores Alferov in the USSR, achieving much higher efficiencies.

Later, dual- and triple-junction solar cells based on GaAs with germanium and indium gallium phosphide layers were developed as the basis of a triple-junction solar cell, which held a record efficiency of over 32 % and can operate also with light as concentrated as 2,000 suns.

On the other hand, a 2013 review argued against these classifications, saying that when rats or mice inhale fine GaAs powders, they get cancer from the resulting lung irritation and inflammation, rather than from a primary carcinogenic effect of the GaAs itself-and that fine GaAs powders are unlikely to be created in the production or use of GaAs.

ScienceDirect Topics

AbstractSurface properties of GaAs passivated with2Sx solution have been analyzed in GaAs wafer and photo-resist-treated GaAs using X-ray photoelectron spectroscopy.

Sulfur treatment on GaAs surface results in the formation of S-Ga and S-As bonds, which remain after successive rinsing for 1 min in DI water.

After oxygen plasma treatment with the HCl-treated sample, the GaAs surface is converted to an As-rich surface, namely, arsenic composition is higher than gallium composition.

The high electron mobility, direct band gap, high quality of the epitaxial growth process, and excellent surface passivation by AlGaAs allowed GaAs to reach the world record efficiency for single-junction thin-film devices in December 2018, up to 29.1%, significantly higher than silicon.

A very thin GaP layer was formed on the GaAs surface.

Used P2S5 to passivate GaAs surfaces exposed to Cl2/Ar plasma.

A multiquantum-well structure was grown on a GaAs substrate via gas-source MBE, and consisted of 20 periods of 30-Å doped quantum wells of GaAs and 500-Å barriers of undoped Al0.5In0.5P, surrounded by GaAs contact layers.

Occupational Safety And Health Administration

Physical Properties Physical Properties Physical description Dark gray crystals with a metallic greenish-blue sheen or gray powder.

Boiling point Molecular weight 144.64 Freezing point/melting point 2260°F Vapor pressure Flash point Vapor density Specific gravity 5.31 Ionization potential Lower explosive limit Upper explosive limit NFPA health rating 3 NFPA fire rating 1 NFPA reactivity rating 2 NFPA special instruction W: Reacts violently or explosively with water.

Vapor hazard ratio Historical exceedance percentage Target organs Monitoring Methods Used by OSHA Monitoring Methods Used by OSHA Analyte code 0260 Sampling group Sampler/Sampling media Sampling time* Sampling volume* Sampling flow rate* Sampling volume* Sampling flow rate* Analytical method instruments Method reference Notes.

All sampling instructions above are recommended guidelines for OSHA Compliance Safety and Health Officers, please see the corresponding OSHA method reference for complete details.

Kreuzer M, Straif K, Marsh JW, Dufey F, Grosche B, Nosske D, Sogl M.: Occupational dust and radiation exposure and mortality from stomach cancer among German uranium miners, 1946-2003.

Arsenic exposure and cardiovascular disease – A systematic review of the epidemiologic evidence.

Chemical Compound

Arseniccovalent bondingcrystal growth In crystal: Vapour growthBinary crystals such as gallium arsenide are grown by a similar method.

One process employs gallium chloride as the gallium carrier.

Arsenic is provided by molecules such as arsenous chloride, arsine, or As4.

These molecules, with hydrogen as the buffer gas, grow crystals.

In crystal: Growth from the meltAluminum arsenide and gallium arsenide have the same crystal structure and the same lattice parameters to within 0.1 percent; they grow excellent crystals on one another.

In materials science: III-V compoundsarsenic, the semiconductor is called gallium arsenide, or GaAs.

Other elements such as indium, phosphorus, and aluminum are often used in the compound to achieve specific performance characteristics.

Gallium Arsenide Gallium arsenide is a III-V group semiconductor.

Doped crystals of gallium arsenide are used in many applications.

In low-power CO2 lasers operating at 9.6-10.6 μm wavelength, gallium arsenide can be an alternative for zinc selenide and can be used for lenses and beam splitters.

Due to their nonlinear optic properties, gallium arsenide crystals can be used in therahertz photonics as THz radiation generators.

Laser rangefinders, gallium arsenide windows are used at wavelengths of 1.064 and 1.55 μm. These cases require maximum possible transmittance between 1 and 2 μm. If window thickness is fixed, the transmittance depends only on crystal growth method.

Gallium arsenide transmission spectra for material thicknesses 2.0, 5.0, 6.5 and 7.5 mm.

2 gives the transmission spectra of the optical-grade gallium arsenide, optical germanium and high-resistivity silicon.

Gallium Arsenide: Another Player In Semiconductor Technology

Gallium arsenide, along with other compounds like gallium nitride and silicon carbide, are now sharing the stage.

With high electron mobility, semiconductor devices built of GaAs can function at frequencies in the hundreds of GHz. While not truly considered a “Wide bandgap” material, GaAs does have a considerably higher bandgap than silicon does.

Another selling point is that GaAs devices are far more resistant to heat and give off less EMI. GaAs features a direct bandgap as opposed to silicon’s indirect bandgap.

A major advantage of silicon is that in the real world of mass manufacturing, silicon is far easier to work with.

As detailed below, silicon carbide and gallium nitride feature bandgaps that are considerably in excess to those of silicon or GaAs.

Gallium nitride has an even higher bandgap than silicon carbide and higher electron mobility, too.

Gallium Nitride has an even higher bandgap than silicon carbide and higher electron mobility, too.

Gallium Arsenide GaAs

Gallium Arsenide Wafers in stock Below are just some of the wother GaAs wafers that we have in stock.

We have the following GaAs substrates from leading manufacturer AXT. Act now! At these prices the wafers won’t last!

100 $29.90 each.25 $35.90 each.10 $39.90 each.5 $45.90 each.1 $59.90.

Freiberger Compound Materials

Wir verwenden Cookies, um Inhalte und Anzeigen zu personalisieren, Funktionen für soziale Medien anbieten zu können und die Zugriffe auf unsere Website zu analysieren.

Außerdem geben wir Informationen zu Ihrer Verwendung unserer Website an unsere Partner für soziale Medien, Werbung und Analysen weiter.

Unsere Partner führen diese Informationen möglicherweise mit weiteren Daten zusammen, die Sie ihnen bereitgestellt haben oder die sie im Rahmen Ihrer Nutzung der Dienste gesammelt haben.

PowerBase-Enhanced Substrates And GaN Pilot Lines Enabling Compact Power Applications

Freiberger Compound Materials GmbH is a worldwide acting company leading supplier of large diameter GaAs substrates for electronic and photonic applications.

Freiberger Compound Materials GmbH is a worldwide leading supplier of large diameter semiinsulating and semiconducting GaAs substrates which are the basis for electronic and photonic devices such as transistors and lasers.

In addition to growth of single crystal semiconductor material, wafering processes such as slicing, surface polishing, removal of damages and final cleaning are important technological steps.

Since 2004, FCM has been working in the field of GaN development and has gradually extended its development activities to material processing and growth processes.

Freiberger Compound Materials GmbH will provide the basis for the benchmark, i.e., the horizontal GaN device on a low dislocation density GaN substrate.

Free standing GaN wafer feature lower defect density compared to thinner epitaxial GaN material on foreign substrates.

Freiberger will contribute to the development of modified HVPE processes near the thermodynamic equilibrium for scaling free standing GaN to wafer diameters up to 4 inch.

Advent International

Advent International is a global private equity firm focused on buyouts of companies in Western and Central Europe, North America, Latin America and Asia.

In 1994, Advent completed fundraising for the first of its flagship series of funds, Advent Global Private Equity II, with $415 million.

Advent crossed the billion dollar mark in 1997, with the raising of the $1.2 billion Advent Global Private Equity III, and in the last few years of the 1990s, Advent raised additional sector funds focused on media and communications as well as healthcare and life sciences.

In August 2010 Advent International was credited with spawning the takeover of Mexicana Airlines by an outside investor group.

Advent International has no equity investment stakes in the takeover according to published sources.

Wilson facilitated Advent’s re-engagement in lululemon by selling 13.85% ownership in the company to Advent for approximately $845 million.

In November 2014, Advent completed a new $2.1 billion private equity fund, its Advent Latin American Private Equity Fund VI, thought to be the largest ever raised for Latin America.

Advent International Acquires European Paytech Mangopay, Invests €75m

Private equity investor Advent International has acquired Mangopay, a payment solutions provider for marketplaces and platforms, for an undisclosed sum.

As part of the transaction, Advent will also take a majority stake in Mangopay’s parent company Leetchi, a donation-based crowdfunding platform based in France.

In addition to the purchase price, Advent will also be investing €75 million of primary capital into Mangopay to facilitate its growth through international expansion and product development.

Former Amazon VP of European consumer business Xavier Garambois has also joined Mangopay as chairman to help accelerate the growth of the paytech firm.

Mangopay offers end-to-end payments solutions to marketplaces and platforms.

Advent has invested $6.5 billion in 17 payments and fintech companies since 2008.

Recent investments include Medius, a provider of cloud-based accounts payable automation; Global Processing Services, a global payment technology platform; and Planet, a global provider of integrated digital payment services.

Welcome to the Advent Community, MangoPay!Thank you – and huge congrats to our portfolio company and our LatAm team! 🎉. Quote Tweet.

We’re delighted to welcome global security leader to the Advent Community! Together with our investment partners, we can’t wait to build on McAfee’s years of success and support the next phase in the company’s growth.

Welcome to the Advent Community, ! With their cutting-edge AIOPs platform, the company is keeping businesses running smoothly with actionable insights and automated solutions.

“Nothing for the faint hearted.” Hear from Advent Managing Partner Ron Ayles on how our long-term focus and commitment to investing in growth have been key trends across our Industrial and Chemicals investments 🧪. 11.9K views.

The digital technology services sector is growing fast, and we’re delighted to welcome to the Advent Community.

Advent Tech has a new home! Today we’re launching the brand-new Advent Tech website to show you how our approach grows the businesses of the future by helping to scale some of the world’s most exciting tech innovators and disruptors.

Congratulations to digital transformation pioneer CI&T, which recently debuted on the New York Stock Exchange, building on its successful partnership with Advent over the last two years.

Piezoelectricity

The piezoelectric effect is a reversible process: materials exhibiting the piezoelectric effect also exhibit the reverse piezoelectric effect, the internal generation of a mechanical strain resulting from an applied electrical field.

The use of piezoelectricity in sonar, and the success of that project, created intense development interest in piezoelectric devices.

The equality between the direct piezoelectric tensor and the transpose of the converse piezoelectric tensor originates from the Maxwell relations of thermodynamics.

While single crystals of ZnO are piezoelectric and pyroelectric, polycrystalline ZnO with randomly oriented grains exhibits neither piezoelectric nor pyroelectric effect.

Not being ferroelectric, polycrystalline ZnO cannot be poled like barium titanate or PZT. Ceramics and polycrystalline thin films of ZnO may exhibit macroscopic piezoelectricity and pyroelectricity only if they are textured, such that the piezoelectric and pyroelectric responses of all individual grains do not cancel.

The semiconductors where the strongest piezoelectricity is observed are those commonly found in the wurtzite structure, i.e. GaN, InN, AlN and ZnO. Since 2006, there have also been a number of reports of strong non linear piezoelectric effects in polar semiconductors.

In most piezoelectric motors, the piezoelectric crystal is excited by a sine wave signal at the resonant frequency of the motor.

ScienceDirect Topics

That’s why the corresponding piezoelectric effect is called the longitudinal shear effect, LS. However, another shear piezoelectric effect is also possible, namely the transverse shear effect, LT, shown in Fig.

Denoting further a field that induces the piezoelectric effect through Еb = E, the artificial piezoelectric modulus is.

If an inverse piezoelectric material is placed under an electric field, it will get strained; this type of piezoelectric effect is called inverse piezoelectric effect.

Out of these materials, piezoelectric ceramics are the materials, which possess large piezoelectric coefficient compared to the other classes.

The measured values of piezoelectric constant are provided in Table 18.2.65.In order to find out the phase’phases responsible for the observed piezoelectric effect in human bone, Marino and Beckeri66 measured the piezoelectric coefficient of natural human cortical bone sample.

The value of piezoelectric constant has been found to be dependent on the angle between stress direction and the axis of bone and the maximum value is observed for the stress acting at an angle of 45° with the bone axis.65,66 The piezoelectric matrix of anisotropic bone has been observed to have only two non-zero components.

The maturity of piezoelectric thin-film deposition technology grew up during the two last decades, raising up the interest for such devices [32-34].Different piezoelectric materials have been used to build piezoelectric accelerometers.

What Is It Used For?

Put a voltage across a piezoelectric crystal and you’re subjecting the atoms inside it to “Electrical pressure.” They have to move to rebalance themselves-and that’s what causes piezoelectric crystals to deform when you put a voltage across them.

In a microphone, we need to convert sound energy into electrical energy-and that’s something piezoelectric crystals can help us with.

If you can make a tiny bit of electricity by pressing one piezoelectric crystal once, could you make a significant amount by pressing many crystals over and over again? What if we buried crystals under city streets and pavements to capture energy as cars and people passed by? This idea, which is known as energy harvesting, has caught many people’s interest.

Inventors have proposed all kinds of ideas for storing energy with hidden piezoelectric devices, from shoes that convert your walking movements into heat to keep your feet warm, and cellphones that charge themselves from your body movements, to roads that power streetlights, contact lenses that capture energy when you blink, and even gadgets that make energy from the pressure of falling rain.

Describes how small, piezoelectric generators could be used to make a variety of self-powered gadgets.

How piezoelectric materials are being used in new cochlear implants to improve deaf people’s hearing.

How Ernest Rutherford and Paul Langevin tried to develop piezoelectric methods of detecting subs in World War I. The Discovery of the Piezoelectric Effect by Shaul Katzir, Archive for History of Exact Sciences, Vol.

Center For Nanoscale Science

Change the shape of a piezoelectric material, and you can create electricity.

Visitors will understand that some materials produce electricity when bent or deformed, because it causes an asymmetry in the charge of the material.

These materials have the ability to convert mechanical energy into electrical energy.

The specific phenomenon depends on the type of piezoelectric material.

The neon bulb flicker is made of a material called polyvinylidene fluoride.

These materials are crystalline in nature, and have charged particles arranged symmetrically throughout their crystal structure.

There is a wide range of applications for piezoelectric materials.

New World Encyclopedia

The piezoelectric effect is reversible in that materials exhibiting the direct piezoelectric effect also exhibit the converse piezoelectric effect.

The first practical application for piezoelectric devices was sonar, first developed during World War I. In France in 1917, Paul Langevin and his coworkers developed an ultrasonic submarine detector.

Over the next few decades, new piezoelectric materials and new applications for those materials were explored and developed.

During World War II, independent research groups in the United States, Russia, and Japan discovered a new class of human-made materials, called ferroelectrics, which exhibited piezoelectric constants many times higher than natural materials.

New materials were the first to be developed-quartz crystals were the first commercially exploited piezoelectric material, but scientists searched for higher-performance materials.

Without many new applications, the growth of the United States’ piezoelectric industry suffered.

Major Japanese piezoelectric developments include new designs of piezoceramic filters, used in radios and televisions, piezo buzzers and audio transducers that could be connected directly into electronic circuits, and the piezoelectric igniter which generates sparks for small engine ignition systems by compressing a ceramic disc.

What Is Piezoelectricity?

Certain materials tend to accumulate electric charges when a mechanical stress is applied to them.

The word piezoelectricity comes from the Greek word piezein, which means squeeze or press and electron, which means “Amber” and is an ancient source of electric charge.

The French physicists Jacques and Pierre Curie discovered in 1880 that electric charges could accumulate in certain solid materials in response to an applied mechanical stress.

First, let’s look at a non-piezoelectric material: the overall charge center of positive and negative ions in the unit cell coincide, and even with applied deformation, these cancel out, and no overall polarisation appears.

In crystalline piezoelectric materials, the unique distribution of charges gives rise to a dipole moment when the material is deformed.

Why charge is changing for piezoelectric materials and not for any other material?

In an uncompressed crystal, the positive charges and negative charges just cancel each other and the resultant charge is null.

What Is Piezoelectricity?

Piezoelectricity is a phenomenon which means that there is a coupling between the electrical and the mechanical state of the material.

In addition to the materials already mentioned, there are many more materials that exhibit piezoelectric properties such as sucrose, silk, Rochelle salt, PVDF, and many ceramics.

Why don’t all materials exhibit this property? The reason for that is that a for piezoelectricity to appear, the material must be crystalline but not have a symmetry center.

In the equilibrium state, when the material is unloaded, the arrangement of charges within the material lattice is such that the unit cell is uncharged, Fig 1 A. However, when the material is mechanically deformed, there will be a charge redistribution within the unit cell.

The sum of the net charge contribution from all the unit cells will be an electrical polarization of the piece of material.

A schematic illustration of the charge distribution in the unit cell of a material with a symmetry center.

Piezoelectricity is a property of certain materials which induces an electric current when mechanical stressed.